Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,ABC transporters,-0.0993341892335712,-2.995064257776123,0.017241379310344827,1.0,0.81,45/45,100.00%,ABCG1;ABCA7;ABCA8;ABCA9;ABCA6;ABCA5;ABCA10;ABCC3;ABCC6;ABCC1;ABCA3;ABCC12;ABCC11;ABCD4;ABCC4;ABCB9;ABCD2;ABCC9;ABCC2;ABCG4;ABCA2;ABCC8;ABCA1;DEFB1;ABCD1;ABCB7;ABCB8;CFTR;ABCB1;ABCB4;ABCA13;ABCB5;ABCC10;TAP1;TAP2;ABCG2;ABCC5;ABCD3;ABCA4;ABCB6;ABCB11;ABCA12;ABCG8;ABCG5;ABCB10
prerank,Glycosaminoglycan degradation,-0.17431904293087502,-2.9943747243972494,0.05813953488372093,0.7397383675387749,0.81,19/19,100.00%,SGSH;NAGLU;GALNS;HEXA;GNS;HPSE2;HGSNAT;IDS;SPAM1;HYAL4;GUSB;ARSB;HEXB;HPSE;IDUA;HYAL2;HYAL1;HYAL3;GLB1
prerank,Intestinal immune network for IgA production,-0.08810796285791062,-2.911668607660456,0.03278688524590164,0.5590892474802862,0.82,45/45,100.00%,ICOSLG;CCL25;TGFB1;TNFRSF13C;MADCAM1;CD40;MAP3K14;CCR10;TNFSF13;TNFRSF17;TNFRSF13B;TNFSF13B;CXCL12;ITGB7;LTBR;IL15RA;AICDA;CD40LG;IL6;HLA-DPB1;HLA-DPA1;HLA-DOA;HLA-DRB1;HLA-DMB;HLA-DOB;HLA-DQA2;HLA-DQB1;HLA-DQA1;HLA-DMA;HLA-DRA;HLA-DRB5;IL4;IL5;CCL28;IL15;IL2;CD86;CD80;CCR9;ITGA4;ICOS;CD28;CXCR4;IL10;PIGR
prerank,beta-Alanine metabolism,-0.08010027456129878,-2.0619084688818776,0.10666666666666667,1.0,1.0,30/30,100.00%,UPB1;MLYCD;SMOX;CNDP1;CNDP2;ACOX1;GADL1;AOC3;AOC2;ALDH3A2;ALDH3A1;ABAT;ALDH6A1;ALDH2;ACADS;ECHS1;GAD2;ALDH3B1;ALDH3B2;CARNS1;ALDH1B1;DPYS;ALDH7A1;ACOX3;DPYD;EHHADH;HIBCH;GAD1;HADHA;ALDH9A1
prerank,Graft-versus-host disease,-0.07301492537313434,-2.023421141069721,0.109375,1.0,1.0,38/38,100.00%,KIR3DL2;KIR3DL1;KIR2DL1;KIR2DL3;KIR3DL3;GZMB;IFNG;PRF1;FAS;KLRD1;KLRC1;IL6;TNF;HLA-DPB1;HLA-DPA1;HLA-DOA;HLA-DRB1;HLA-DMB;HLA-DOB;HLA-DQA2;HLA-DQB1;HLA-DQA1;HLA-DMA;HLA-DRA;HLA-DRB5;HLA-B;HLA-C;HLA-E;HLA-A;HLA-G;HLA-F;IL2;CD86;CD80;CD28;IL1A;IL1B;FASLG
prerank,Autoimmune thyroid disease,-0.06032011466794075,-1.9402523402523406,0.11864406779661017,1.0,1.0,50/50,100.00%,CD40;TSHR;GZMB;PRF1;FAS;IFNA1;IFNA8;IFNA2;IFNA13;IFNA6;IFNA5;IFNA14;IFNA17;IFNA16;IFNA10;IFNA7;IFNA21;IFNA4;TG;CD40LG;CGA;HLA-DPB1;HLA-DPA1;HLA-DOA;HLA-DRB1;HLA-DMB;HLA-DOB;HLA-DQA2;HLA-DQB1;HLA-DQA1;HLA-DMA;HLA-DRA;HLA-DRB5;HLA-B;HLA-C;HLA-E;HLA-A;HLA-G;HLA-F;IL4;IL5;IL2;CD86;CD80;CTLA4;CD28;TPO;IL10;FASLG;TSHB
prerank,Type I diabetes mellitus,-0.07302146460877093,-1.9269783488631111,0.13793103448275862,1.0,1.0,41/41,100.00%,GZMB;IFNG;PRF1;FAS;GAD2;INS;PTPRN2;TNF;HLA-DPB1;HLA-DPA1;HLA-DOA;HLA-DRB1;HLA-DMB;HLA-DOB;HLA-DQA2;HLA-DQB1;HLA-DQA1;HLA-DMA;HLA-DRA;HLA-DRB5;LTA;HLA-B;HLA-C;HLA-E;HLA-A;HLA-G;HLA-F;ICA1;IL12B;CPE;IL2;CD86;IL12A;CD80;PTPRN;HSPD1;CD28;GAD1;IL1A;IL1B;FASLG
prerank,Allograft rejection,-0.07300838730859924,-1.8227526273684673,0.16176470588235295,1.0,1.0,35/35,100.00%,CD40;GZMB;IFNG;PRF1;FAS;CD40LG;TNF;HLA-DPB1;HLA-DPA1;HLA-DOA;HLA-DRB1;HLA-DMB;HLA-DOB;HLA-DQA2;HLA-DQB1;HLA-DQA1;HLA-DMA;HLA-DRA;HLA-DRB5;HLA-B;HLA-C;HLA-E;HLA-A;HLA-G;HLA-F;IL12B;IL4;IL5;IL2;CD86;IL12A;CD80;CD28;IL10;FASLG
prerank,Arginine biosynthesis,-0.08357202530134861,-1.7938023839447959,0.1375,1.0,1.0,22/22,100.00%,NAGS;NOS2;GOT2;GPT2;ARG2;NOS1;GLS2;GLUD1;GOT1;ASS1;GPT;GOT1L1;GLUD2;OTC;NOS3;ASL;ARG1;ACY1;ABHD14A-ACY1;CPS1;GLS;GLUL
prerank,Histidine metabolism,-0.0800811552691252,-1.6744826692161854,0.14285714285714285,1.0,1.0,22/22,100.00%,FTCD;CNDP1;CNDP2;ALDH3A2;ASPA;ALDH3A1;HAL;AMDHD1;ALDH2;HDC;ALDH3B1;ALDH3B2;CARNS1;CARNMT1;ALDH1B1;AOC1;MAOB;MAOA;ALDH7A1;UROC1;HNMT;ALDH9A1
prerank,Citrate cycle (TCA cycle),-0.06255222633400978,-1.5613421427646068,0.21739130434782608,1.0,1.0,30/30,100.00%,PCK1;ACO2;IDH3B;ACLY;DLST;IDH3A;IDH2;SUCLA2;PCK2;CS;OGDHL;DLAT;SDHD;PC;ACO1;IDH3G;PDHA1;DLD;MDH2;OGDH;SDHA;PDHA2;SUCLG2;PDHB;IDH1;MDH1;SUCLG1;FH;SDHC;SDHB
prerank,NF-kappa B signaling pathway,-0.03256968536906329,-1.559555555555556,0.06896551724137931,1.0,1.0,102/102,100.00%,CARD10;PLCG1;LBP;ICAM1;TNFSF14;TICAM1;RELB;TNFRSF13C;TAB1;PIAS4;CD40;GADD45B;BCL2L1;CSNK2A1;MALT1;BCL2;TNFRSF11A;CARD14;MAP3K14;TRIM25;CCL4L2;CCL4;CCL13;PLCG2;CSNK2A2;TRADD;LAT;PRKCB;UBE2I;CYLD;BCL2A1;TRAF3;TNFSF11;NFKBIA;TNFSF13B;IRAK4;CXCL12;LTBR;TNFRSF1A;ERC1;PLAU;BLNK;PRKCQ;NFKB2;CHUK;BIRC2;BIRC3;ATM;RELA;TIRAP;TRAF6;TRAF2;CSNK2A3;PIDD1;TRAF1;TLR4;SYK;GADD45G;DDX58;CCL21;CCL19;LY96;IKBKB;LYN;IRAK1;IKBKG;CD40LG;BTK;EDA;XIAP;EDA2R;TAB3;CARD11;TAB2;TNFAIP3;MAP3K7;LTB;TNF;CSNK2B;LTA;RIPK1;CD14;TICAM2;NFKB1;VCAM1;MYD88;CXCL2;CXCL3;CXCL1;CXCL8;CFLAR;EDAR;IL1R1;IL1B;ZAP70;TRAF5;PARP1;PTGS2;EDARADD;GADD45A;BCL10;LCK
prerank,Asthma,-0.07454491196657714,-1.44030729500808,0.22535211267605634,1.0,1.0,28/28,100.00%,CD40;EPX;CCL11;RNASE3;MS4A2;PRG2;CD40LG;TNF;HLA-DPB1;HLA-DPA1;HLA-DOA;HLA-DRB1;HLA-DMB;HLA-DOB;HLA-DQA2;HLA-DQB1;HLA-DQA1;HLA-DMA;HLA-DRA;HLA-DRB5;IL9;IL4;IL13;IL5;IL3;IL10;FCER1G;FCER1A
prerank,Maturity onset diabetes of the young,-0.0721830985915493,-1.4402080673085207,0.21052631578947367,1.0,1.0,26/26,100.00%,FOXA3;FOXA2;NKX2-2;HNF4A;HNF1B;HNF1A;PDX1;ONECUT1;IAPP;HHEX;NEUROG3;PAX6;INS;MAFA;HNF4G;MNX1;PAX4;BHLHA15;GCK;RFX6;NKX6-1;HES1;SLC2A2;NEUROD1;NR5A2;PKLR
prerank,"Glycine, serine and threonine metabolism",-0.04830139112782853,-1.4261516057331187,0.2028985507246377,1.0,1.0,40/40,100.00%,CBSL;CBS;GCAT;GAMT;AOC3;AOC2;PIPOX;SHMT1;SRR;GCSH;GATM;SDSL;SDS;DAO;SHMT2;PGAM1;SARDH;PSAT1;GRHPR;GLDC;BPGM;ALAS2;PGAM4;MAOB;MAOA;DLD;PSPH;PGAM2;GNMT;AGXT2;ALDH7A1;BHMT;DMGDH;AMT;GLYCTK;ALAS1;CHDH;AGXT;PHGDH;CTH
prerank,Tryptophan metabolism,-0.05221518987341772,-1.356414801684024,0.15873015873015872,1.0,1.0,42/42,100.00%,IL4I1;GCDH;AFMID;AANAT;ALDH3A2;CYP1A2;CYP1A1;DLST;ALDH2;TPH2;ECHS1;DHTKD1;ACAT1;CAT;TPH1;KYAT1;ALDH1B1;IDO2;IDO1;AOC1;MAOB;MAOA;ASMT;DLD;DDC;INMT;ACAT2;ALDH8A1;ALDH7A1;AADAT;HADH;TDO2;EHHADH;KYNU;AOX1;ACMSD;HAAO;CYP1B1;HADHA;KMO;ALDH9A1;KYAT3
prerank,Ribosome biogenesis in eukaryotes,-0.02749633880271377,-1.342462678190594,0.17307692307692307,1.0,1.0,79/79,100.00%,PWP2;POP4;EIF6;FBL;RRP7A;SNU13;XRN2;REXO1;NXT1;NOP56;CSNK2A1;UTP18;UTP6;NOB1;UTP4;CSNK2A2;TBL3;REXO5;RPP25;IMP3;FCF1;EFL1;NOP10;UTP14C;POP5;RAN;BMS1;EMG1;RPP30;RPP38;GTPBP4;REXO2;NAT10;NXF1;CSNK2A3;NOL6;RPP25L;RMRP;RCL1;TCOF1;POP1;DKC1;UTP14A;GNL3L;NXF5;NXF2;NXF2B;NXF3;RBM28;POP7;SBDS;MDN1;CSNK2B;RIOK1;RPP40;NHP2;FBLL1;WDR36;RIOK2;UTP15;AK6;DROSHA;GAR1;SPATA5;LSG1;XRN1;NMD3;GNL3;WDR75;NOP58;IMP4;MPHOSPH10;XPO1;NXT2;NVL;HEATR1;WDR3;WDR43;GNL2
prerank,Collecting duct acid secretion,-0.061740920891647524,-1.2870571610693413,0.2345679012345679,1.0,1.0,27/27,100.00%,ATP6V1E1;ATP4A;ATP6V0A1;SLC4A1;ATP6V0D1;ATP6V0C;ATP6V1D;ATP4B;ATP6V0A2;TCIRG1;ATP6V1G1;ATP6V1C1;ATP6V0D2;CA2;ATP6V1B2;ATP6V0E2;ATP6V1F;ATP6V0A4;ATP6V1G2;ATP6V0E1;SLC12A7;ATP6V1A;ATP6V1B1;ATP6V1C2;ATP6V1E2;ATP6V1G3;CLCNKB
prerank,Starch and sucrose metabolism,-0.05342645654250239,-1.2809605216077609,0.2361111111111111,1.0,1.0,34/34,100.00%,GYS1;GPI;PYGB;GAA;G6PC3;GANC;PGM2L1;PYGL;GYS2;HK1;HKDC1;TREH;PYGM;GYG2;MGAM;MGAM2;GCK;ENPP1;ENPP3;HK3;GYG1;PGM2;AGL;SI;GBE1;G6PC2;UGP2;HK2;AMY1C;AMY1B;AMY1A;AMY2A;AMY2B;PGM1
prerank,Nucleotide excision repair,-0.03794936104144273,-1.2258782505471673,0.23076923076923078,1.0,1.0,46/46,100.00%,LIG1;ERCC1;ERCC2;POLD1;RAD23A;RBX1;PCNA;XPC;ERCC4;RPA1;POLD3;POLE2;MNAT1;CUL4A;ERCC5;BIVM-ERCC5;RFC5;GTF2H3;RFC3;POLE;ERCC6;POLD4;DDB1;DDB2;GTF2H1;RAD23B;POLE3;XPA;CETN2;CUL4B;RPA4;RFC2;POLD2;RPA3;GTF2H5;GTF2H4;GTF2H2;CCNH;GTF2H2C;CDK7;ERCC8;RFC1;RFC4;ERCC3;POLE4;RPA2
prerank,One carbon pool by folate,-0.061011993555701416,-1.2153595562501376,0.2839506172839506,1.0,1.0,20/20,100.00%,FTCD;GART;TYMS;SHMT1;ST20-MTHFS;MTHFS;MTHFD1;ALDH1L2;MTFMT;SHMT2;MTHFD1L;DHFR;ALDH1L1;AMT;DHFR2;MTHFD2L;ATIC;MTHFD2;MTR;MTHFR
prerank,GABAergic synapse,-0.022721157583186342,-1.164572479313515,0.36666666666666664,1.0,1.0,89/89,100.00%,PRKCG;KCNJ6;GNG8;SLC32A1;SRC;PRKACA;CACNA1A;SLC12A5;GNG7;GNGT2;SLC6A11;NSF;HAP1;PRKCA;GABARAP;GABARAPL2;ADCY7;ABAT;GNG13;PRKCB;GNAO1;ADCY9;GABRG3;GABRA5;GABRB3;GNG2;GPHN;ADCY4;GNB5;SLC38A1;SLC38A2;GLS2;ADCY6;SLC6A13;SLC6A12;GNB3;CACNA1C;GAD2;GNG3;GABARAPL1;CACNA1B;GABBR2;GNG10;PRKACG;ADCY8;GABRA3;GABRQ;GABRE;CACNA1F;SLC38A5;GNB2;GNGT1;GNG11;GNAI1;ADCY1;GABRR1;GABRR2;GABBR1;GABRP;GABRG2;GABRA1;GABRA6;GABRB2;ADCY2;GABRB1;GABRA4;GABRA2;GABRG1;GNB4;ADCY5;GABRR3;GNAI2;CACNA1D;SLC38A3;SLC6A1;PLCL1;GLS;TRAK2;GAD1;ADCY3;GNG4;CACNA1S;GLUL;GNAI3;GNG12;GNG5;PRKACB;GABRD;GNB1
prerank,Homologous recombination,-0.037943696450428395,-1.1393289337434118,0.27586206896551724,1.0,1.0,41/41,100.00%,TOP3B;POLD1;RBBP8;BRIP1;EME1;BRCA1;RAD51C;RAD51D;TOP3A;RPA1;PALB2;RAD51B;BLM;RAD51;POLD3;XRCC3;SYCP3;BRCA2;RAD52;BABAM1;ATM;MUS81;MRE11;POLD4;RAD54B;NBN;BRCC3;RPA4;XRCC2;SSBP1;SEM1;POLD2;RPA3;UIMC1;RAD50;ABRAXAS1;TOPBP1;BARD1;BABAM2;RAD54L;RPA2
prerank,Proximal tubule bicarbonate reclamation,-0.06065940623601373,-1.128555655192187,0.2967032967032967,1.0,1.0,23/23,100.00%,ATP1A3;PCK1;SLC25A10;CA4;ATP1B2;PCK2;GLS2;GLUD1;FXYD2;CA2;ATP1B4;GLUD2;AQP1;SLC9A3;SLC4A4;ATP1B3;SLC38A3;GLS;MDH1;ATP1B1;ATP1A4;ATP1A2;ATP1A1
prerank,p53 signaling pathway,-0.024025100851636037,-1.10058177519211,0.3181818181818182,1.0,1.0,73/73,100.00%,CHEK2;GTSE1;BID;BBC3;BAX;CCNE1;GADD45B;BCL2L1;PMAIP1;BCL2;SERPINB5;PPM1D;TP53;TSC2;SIAH1;THBS1;CCNB2;SIVA1;IGF1;APAF1;MDM2;CDK4;CDK2;CCND2;FAS;PTEN;AIFM2;CDK1;SESN3;ATM;TP53AIP1;CHEK1;EI24;CCND1;DDB2;CD82;PIDD1;CDKN2A;GADD45G;RRM2B;CCNE2;ADGRB1;TNFRSF10B;TNFRSF10A;SERPINE1;CDK6;IGFBP3;CYCS;PERP;SESN1;CDKN1A;CCND3;CCNG1;CCNB1;CASP3;ZMAT3;ATR;SHISA5;RPRM;RCHY1;CCNG2;CASP8;STEAP3;RRM2;TP53I3;MDM4;GORAB;COP1;CASP9;GADD45A;SESN2;SFN;TP73
prerank,Steroid hormone biosynthesis,-0.030797263793051945,-1.0963225520602569,0.375,1.0,1.0,61/61,100.00%,COMT;SULT2B1;HSD11B1L;HSD17B1;DHRS11;HSD17B2;HSD11B2;CYP1A2;CYP1A1;CYP11A1;LRTOMT;CYP19A1;HSD17B6;CYP2E1;CYP17A1;AKR1C1;AKR1C2;AKR1C3;AKR1C4;HSD17B12;HSD17B3;CYP11B2;CYP11B1;CYP7B1;CYP7A1;STS;AKR1D1;CYP3A4;CYP3A7-CYP3A51P;CYP3A7;CYP3A5;HSD17B8;CYP21A2;SRD5A1;SRD5A3;UGT1A1;UGT1A3;UGT1A4;UGT1A5;UGT1A6;UGT1A7;UGT1A9;UGT1A10;UGT1A8;SULT1E1;UGT2A2;UGT2B4;UGT2B28;UGT2B11;UGT2B7;UGT2A3;UGT2B10;UGT2B15;UGT2B17;UGT2A1;CYP1B1;HSD11B1;HSD17B7;HSD3B1;HSD3B2;SRD5A2
prerank,Viral protein interaction with cytokine and cytokine receptor,-0.01985645933014354,-1.074587081726879,0.3235294117647059,1.0,1.0,98/98,100.00%,IL10RB;IL2RB;CCL25;TNFSF14;CCR10;CCR7;CCL5;CCL14;CCL4L2;CCL4;CCL3;CCL18;CCL23;CCL3L1;CCL16;CCL1;CCL13;CCL11;CCL7;CCL2;CCL8;CCL15;IL34;CCL22;CX3CL1;CCL17;CXCL12;LTBR;TNFRSF1A;IL2RA;CXCR5;IL10RA;IL18;CCL27;CCL21;CCL19;TNFRSF10B;TNFRSF10A;TNFRSF10D;TNFRSF10C;IL2RG;CXCR3;CSF1R;CCL24;CCL26;IL6;CCR6;IL20RA;TNF;LTA;CXCL14;IL6ST;CCL28;IL2;TNFSF10;IL20RB;ACKR4;CCR5;CCR2;CCR1;CCR3;CCR9;XCR1;ACKR3;CX3CR1;CCR8;CCR4;CCL20;CXCL2;CXCL3;CXCL5;PPBP;PF4;CXCL1;CXCL9;CXCL10;PF4V1;CXCL6;CXCL8;CXCL13;CXCL11;IL18RAP;IL18R1;CXCR4;IL37;CXCR1;CXCR2;IL24;IL20;IL19;IL10;XCL1;XCL2;CSF1;IL6R;TNFRSF14;TNFRSF1B;IL22RA1
prerank,Glycerolipid metabolism,-0.030587251329231138,-1.0687282566679552,0.2962962962962963,1.0,1.0,60/60,100.00%,AGPAT3;LPIN3;PNPLA3;PLPP2;LIPG;DGKE;ALDH3A2;LPIN2;DGAT2;MOGAT2;ALDH2;DGKH;LIPC;DGKA;PLPP4;PNLIP;PNLIPRP3;GPAM;LIPF;PNLIPRP1;TKFC;DGKZ;AGPAT2;PNPLA2;CEL;ALDH1B1;DGAT1;PLPP5;GPAT4;LPL;AKR1B10;AKR1B1;AGPAT5;DGKK;GK;AGK;DGKI;MOGAT3;DGKB;AGPAT4;AGPAT1;MBOAT1;ALDH7A1;PLPP1;GPAT3;GK2;DGKG;DGKQ;MGLL;GLYCTK;DGKD;MOGAT1;GPAT2;MBOAT2;LPIN1;GLA;ALDH9A1;PLPP3;AKR1A1;LCLAT1
prerank,Cytokine-cytokine receptor interaction,-0.013806587456760415,-1.0487433358720486,0.3333333333333333,1.0,1.0,293/293,100.00%,IFNGR2;IFNAR1;IL10RB;IFNAR2;OSM;LIF;CSF2RB;IL2RB;IL17C;IL17RA;IL11;CXCL17;GDF5;CCL25;GDF1;GDF15;IL12RB1;TGFB1;IFNL1;IFNL2;IFNL3;IL27RA;EPOR;BMP7;TNFSF14;CD70;TNFSF9;EBI3;TNFRSF13C;TNFRSF6B;CD40;AMH;BMP2;TNFRSF11A;NGFR;TGFBR2;CCR10;CCR7;CSF3;CSH2;GH2;CSH1;CCL5;GH1;CCL14;CCL4L2;CCL4;CCL3;CCL18;CCL23;CCL3L1;CCL16;CCL1;CCL13;CCL11;CCL7;CCL2;CCL8;CCL15;CXCL16;TNFSF13;TNFSF12;TNFRSF17;IL34;TNFRSF13B;IL21R;IL4R;IL27;CCL22;CX3CL1;CCL17;CTF1;IL32;TNFRSF12A;IL16;TGFB3;RELT;BMP4;TNFSF11;TNFSF13B;IL25;IL31;IFNG;IL26;IL22;TNFRSF19;IL17D;IL23A;INHBE;GDF11;GDF2;CXCL12;GDF10;AMHR2;INHBC;ACVR1B;ACVRL1;CD4;CD27;LTBR;TNFRSF1A;NODAL;BMPR1A;FAS;IL2RA;IL15RA;CXCR5;IL10RA;IL18;CLCF1;GDF3;CNTF;TGFBR1;TNFSF8;TNFSF15;IFNE;IFNA1;IFNA8;IFNA2;IFNA13;IFNA6;IFNA5;IFNA14;IFNA17;IFNA16;IFNA10;IFNA7;IFNA21;IFNW1;IFNB1;IFNA4;IFNK;IL11RA;CCL27;CNTFR;IL33;CCL21;CCL19;TNFRSF11B;GDF6;IL7;TNFRSF10B;TNFRSF10A;TNFRSF10D;TNFRSF10C;CD40LG;IL9R;EDA;IL13RA2;IL2RG;CXCR3;EDA2R;BMP15;IL3RA;CSF2RA;CRLF2;LEP;EPO;CSF1R;CCL24;CCL26;INHBA;IL6;CCR6;IFNGR1;IL20RA;BMP5;IL17F;IL17A;TNFRSF21;LTB;TNF;LTA;PRL;BMP6;CSF2;PRLR;IL12B;IL9;IL17B;CXCL14;GDF9;IL4;IL13;IL5;TSLP;IL6ST;IL31RA;GHR;CCL28;IL3;OSMR;IL7R;LIFR;IL15;IL21;IL2;BMPR1B;BMP3;THPO;TNFSF10;IL1RAP;IL12A;IL20RB;ACKR4;CCR5;CCR2;CCR1;CCR3;CXCR6;CCR9;XCR1;ACVR2A;IL17RB;ACKR3;CX3CR1;ACVR2B;CCR8;CCR4;IL5RA;IL17RC;IL17RE;INHA;CCL20;CXCL2;CXCL3;CXCL5;PPBP;PF4;CXCL1;CXCL9;CXCL10;PF4V1;CXCL6;CXCL8;CXCL13;CXCL11;MSTN;BMPR2;EDAR;IL18RAP;IL18R1;IL1RL1;IL1RL2;IL1R1;IL1R2;CXCR4;ACVR1;ACVR1C;IL36G;IL37;IL36A;CXCR1;CXCR2;IL36B;IL1F10;IL1A;IL36RN;IL1B;INHBB;IL1RN;BMP10;GDF7;TGFB2;IL13RA1;IL24;IL20;IL19;IL10;XCL1;XCL2;TNFSF4;TNFSF18;FASLG;NGF;LEPR;IL12RB2;IL23R;CSF1;IL6R;BMP8B;BMP8A;CSF3R;TNFRSF14;TNFRSF1B;TNFRSF8;IL22RA1;IFNLR1;TNFRSF9;TNFRSF25;MPL;TNFRSF4;TNFRSF18
prerank,Ovarian steroidogenesis,0.9980290859139368,1.0052971147943524,0.061224489795918366,1.0,0.99,1/51,0.20%,GNAS
prerank,Endocrine and other factor-regulated calcium reabsorption,0.9980289681947141,1.0047744751985856,0.08571428571428572,1.0,1.0,1/53,0.20%,GNAS
prerank,Glutamatergic synapse,0.9980253709909047,1.0046480810352272,0.1388888888888889,1.0,1.0,1/114,0.20%,GNAS
prerank,Long-term depression,0.9980285560666706,1.004345184417711,0.1702127659574468,1.0,1.0,1/60,0.20%,GNAS
prerank,Regulation of lipolysis in adipocytes,0.9980289093298291,1.0040993206040199,0.13636363636363635,1.0,1.0,1/54,0.20%,GNAS
prerank,Prolactin signaling pathway,0.9986853113421776,1.0040699162206965,0.16666666666666666,1.0,1.0,1/70,0.13%,FOS
prerank,Bile secretion,0.9980267878497967,1.0039062371513081,0.15625,1.0,1.0,1/90,0.20%,GNAS
prerank,Morphine addiction,0.9980267288546057,1.003824191388305,0.1267605633802817,1.0,1.0,1/91,0.20%,GNAS
prerank,Cushing syndrome,0.9950873198933585,1.0024811360578074,0.1927710843373494,1.0,1.0,3/155,0.50%,GNAS;CTNNB1;ATF4
prerank,AMPK signaling pathway,0.9963194589903946,1.002470366652413,0.24050632911392406,1.0,1.0,1/119,0.37%,EEF2
prerank,Arginine and proline metabolism,0.9973124701385571,1.0021377190634908,0.2972972972972973,1.0,1.0,1/50,0.27%,CKB
prerank,Phospholipase D signaling pathway,0.9949088077625705,1.0020586527512798,0.23684210526315788,1.0,1.0,3/147,0.52%,GNAS;ARF1;RHOA
prerank,mTOR signaling pathway,0.9948777857656361,1.0019428453222443,0.24675324675324675,1.0,1.0,2/154,0.52%,RPS6;RHOA
prerank,Cortisol synthesis and secretion,0.9950706539599079,1.0019161708247029,0.24561403508771928,1.0,1.0,2/65,0.50%,GNAS;ATF4
prerank,Purine metabolism,0.9953009487893208,1.0019097149796745,0.2923076923076923,1.0,1.0,1/127,0.47%,GUK1
prerank,Hematopoietic cell lineage,0.9953651097422404,1.00183773904288,0.2878787878787879,1.0,1.0,1/96,0.47%,ANPEP
prerank,Gastric cancer,0.9952679026026535,1.0017403826781368,0.3291139240506329,1.0,1.0,1/149,0.47%,CTNNB1
prerank,Insulin secretion,0.9950675594882217,1.0017125770454485,0.22727272727272727,1.0,1.0,2/86,0.50%,GNAS;ATF4
prerank,Chemokine signaling pathway,0.9948422694014634,1.0016159035096324,0.3068181818181818,1.0,1.0,1/190,0.52%,RHOA
prerank,Cholinergic synapse,0.9950635751682873,1.0015605893208488,0.28378378378378377,1.0,1.0,2/113,0.50%,FOS;ATF4
prerank,"Growth hormone synthesis, secretion and action",0.9950926119871928,1.001522465681119,0.2894736842105263,1.0,1.0,3/119,0.50%,FOS;GNAS;ATF4
prerank,Sphingolipid metabolism,0.9952223118038759,1.0014847014879376,0.3076923076923077,1.0,1.0,1/49,0.48%,PSAP
prerank,Basal cell carcinoma,0.9952800597460791,1.0013094119137627,0.35294117647058826,1.0,1.0,1/63,0.47%,CTNNB1
prerank,Inositol phosphate metabolism,0.9952487673688929,1.001299543316314,0.32075471698113206,1.0,1.0,1/73,0.48%,TPI1
prerank,Thyroid hormone signaling pathway,0.9953317173893527,1.0012243068414908,0.390625,1.0,1.0,3/121,0.47%,ACTB;ACTG1;CTNNB1
prerank,Sphingolipid signaling pathway,0.9948532272060804,1.0011505324243266,0.3246753246753247,1.0,1.0,1/119,0.52%,RHOA
prerank,Pancreatic secretion,0.99488590483596,1.0010755840479622,0.3548387096774194,1.0,1.0,2/101,0.52%,GNAS;RHOA
prerank,Endometrial cancer,0.9952807646356033,1.0010008861870883,0.36363636363636365,1.0,1.0,1/58,0.47%,CTNNB1
prerank,Thyroid hormone synthesis,0.9948003825005974,1.00096764670508,0.4,1.0,1.0,4/74,0.53%,GNAS;TTR;ATF4;HSP90B1
prerank,Shigellosis,0.9936672769290796,1.0007573372023968,0.31868131868131866,1.0,1.0,13/219,0.67%,ACTB;ACTG1;RPS27A;MYL9;UBB;UBA52;PFN1;UBC;ARF1;MYL12B;RHOA;JUN;ITGB1
prerank,Autophagy,0.9943117178612059,1.0007559789851574,0.3924050632911392,1.0,1.0,1/136,0.57%,HMGB1
prerank,"Parathyroid hormone synthesis, secretion and action",0.9941373534338358,1.000688884392674,0.3466666666666667,1.0,1.0,6/106,0.60%,FOS;GNAS;NACA;ATF4;RHOA;EGR1
prerank,Fructose and mannose metabolism,0.9952547228937237,1.0006849952919505,0.4482758620689655,1.0,1.0,1/31,0.48%,TPI1
prerank,Lysosome,0.9941933552828495,1.0006664921092094,0.37037037037037035,1.0,1.0,3/128,0.59%,PSAP;CTSA;CD63
prerank,Adherens junction,0.9949502494995071,1.0006616647273652,0.40350877192982454,1.0,1.0,4/71,0.52%,ACTB;ACTG1;CTNNB1;RHOA
prerank,Choline metabolism in cancer,0.9934509569377992,1.000646560789957,0.3103448275862069,1.0,1.0,2/98,0.66%,FOS;JUN
prerank,Wnt signaling pathway,0.9934677733497137,1.0005133744155534,0.4024390243902439,1.0,1.0,3/165,0.66%,CTNNB1;RHOA;JUN
prerank,Ubiquitin mediated proteolysis,0.9938022096469955,1.0004335065995331,0.4074074074074074,1.0,1.0,5/139,0.63%,RPS27A;UBB;UBA52;UBC;ELOB
prerank,Thyroid cancer,0.9952837228739441,1.0004172405677845,0.46875,1.0,1.0,1/37,0.47%,CTNNB1
prerank,Renin-angiotensin system,0.9946292704759063,1.0002667244569656,0.4444444444444444,1.0,1.0,2/23,0.54%,ANPEP;CTSA
prerank,Apoptosis,0.9935924306844723,1.0002262497320729,0.4074074074074074,1.0,1.0,7/140,0.66%,ACTB;ACTG1;FOS;TUBA1A;TUBA1B;ATF4;JUN
prerank,Yersinia infection,0.993503383030956,1.000137383390465,0.44155844155844154,1.0,1.0,7/136,0.67%,ACTB;ACTG1;FOS;FN1;RHOA;JUN;ITGB1
prerank,Osteoclast differentiation,0.9934456648609824,1.0001132710584058,0.45569620253164556,1.0,1.0,2/125,0.66%,FOS;JUN
prerank,Base excision repair,0.9943292045963289,1.0000741639340787,0.47058823529411764,1.0,1.0,1/33,0.57%,HMGB1
prerank,TNF signaling pathway,0.9934781307963862,1.0000359698689616,0.4027777777777778,1.0,1.0,3/112,0.66%,FOS;ATF4;JUN
prerank,Dilated cardiomyopathy,0.9935412492898364,1.0000174754057933,0.4032258064516129,1.0,1.0,8/95,0.67%,ACTB;ACTG1;GNAS;TPM1;TPM2;DES;TPM4;ITGB1
prerank,Malaria,0.9939679885332062,1.0000142309364748,0.5,1.0,1.0,2/50,0.61%,CD81;HBA2
prerank,Olfactory transduction,0.9916656601038772,1.0000024606662499,0.41414141414141414,1.0,1.0,2/422,0.83%,CALM1;CALM2
prerank,Cell adhesion molecules,0.9933217537134643,0.9999291738915352,0.42168674698795183,1.0,1.0,1/146,0.67%,ITGB1
prerank,Hypertrophic cardiomyopathy,0.9935123176273616,0.9999221809262332,0.4482758620689655,1.0,1.0,7/90,0.67%,ACTB;ACTG1;TPM1;TPM2;DES;TPM4;ITGB1
prerank,T cell receptor signaling pathway,0.993479691332177,0.9999215481648662,0.48484848484848486,1.0,1.0,3/104,0.66%,FOS;RHOA;JUN
prerank,Gap junction,0.993931240657698,0.9998892492002791,0.4444444444444444,1.0,1.0,5/88,0.62%,GNAS;TUBB;TUBA1A;TUBA1B;TUBB4B
prerank,Rheumatoid arthritis,0.993452719064845,0.9998551102342631,0.4461538461538462,1.0,1.0,2/89,0.66%,FOS;JUN
prerank,Chagas disease,0.9935101833298439,0.99985239657659,0.5068493150684932,1.0,1.0,4/101,0.66%,FOS;GNAS;CALR;JUN
prerank,Colorectal cancer,0.9935130933875403,0.999769032864635,0.4745762711864407,1.0,1.0,4/86,0.66%,FOS;CTNNB1;RHOA;JUN
prerank,Bacterial invasion of epithelial cells,0.993486509904688,0.9997481912994454,0.4791666666666667,1.0,1.0,6/69,0.67%,ACTB;ACTG1;FN1;CTNNB1;RHOA;ITGB1
prerank,Axon guidance,0.9934344645640963,0.9997419948170087,0.5172413793103449,1.0,1.0,5/182,0.67%,MYL9;CFL1;MYL12B;RHOA;ITGB1
prerank,Th1 and Th2 cell differentiation,0.99345252331978,0.9996933129653631,0.5522388059701493,1.0,1.0,2/90,0.66%,FOS;JUN
prerank,Breast cancer,0.993471294660238,0.9996673709603406,0.4936708860759494,1.0,1.0,3/147,0.66%,FOS;CTNNB1;JUN
prerank,Basal transcription factors,0.9945064787723175,0.9996347052754558,0.4482758620689655,1.0,1.0,1/44,0.55%,GTF2I
prerank,VEGF signaling pathway,0.9930404133934705,0.9995676251453179,0.4523809523809524,1.0,1.0,1/59,0.70%,HSPB1
prerank,Inflammatory bowel disease,0.993427931292009,0.9994254199706292,0.559322033898305,1.0,1.0,1/63,0.66%,JUN
prerank,Toll-like receptor signaling pathway,0.9934501734657257,0.9993825329018781,0.47692307692307695,1.0,1.0,2/102,0.66%,FOS;JUN
prerank,Pathways of neurodegeneration,0.9910217654171718,0.9993802458469931,0.45,1.0,1.0,36/458,0.99%,RPS27A;ATP5F1E;TUBB;UBB;UBA52;UBC;TUBA1A;TUBA1B;COX7A2;COX5B;ATP5MC2;CTNNB1;ATP5F1A;ATF4;NDUFA13;UQCRQ;TUBB4B;NDUFA11;ATP5F1B;COX8A;COX6A1;NDUFA4;UQCR11;COX6B1;COX7C;UQCRH;CALM1;CALM2;UQCRB;SLC25A6;COX6C;COX4I1;FUS;NDUFB1;UQCR10;NDUFB2
prerank,Tyrosine metabolism,0.9936720195809206,0.9993752028714401,0.5625,1.0,1.0,1/36,0.64%,MIF
prerank,B cell receptor signaling pathway,0.9934845631967482,0.999340185697378,0.5789473684210527,1.0,1.0,3/79,0.66%,FOS;CD81;JUN
prerank,Endocytosis,0.9916781830198882,0.9993309668211443,0.5054945054945055,1.0,1.0,3/252,0.83%,ARF1;RHOA;HSPA8
prerank,MAPK signaling pathway,0.9914270244254599,0.9992679341911366,0.5104166666666666,1.0,1.0,8/294,0.87%,FOS;FLNA;ATF4;JUN;HSPB1;STMN1;HSPA8;DUSP1
prerank,PD-L1 expression and PD-1 checkpoint pathway in cancer,0.993452719064845,0.9992591129368007,0.603448275862069,1.0,1.0,2/89,0.66%,FOS;JUN
prerank,Epithelial cell signaling in Helicobacter pylori infection,0.993426556710888,0.9992027444642908,0.5660377358490566,1.0,1.0,1/70,0.66%,JUN
prerank,Coronavirus disease,0.9918040169323609,0.9991910931439836,0.4787234042553192,1.0,1.0,82/229,1.06%,RPS8;RPS12;RPL34;RPL11;RPL32;RPL13A;RPS15A;RPS19;RPL30;RPS27A;RPL19;RPLP0;RPL39;RPS15;RPL35A;RPL3;RPS6;RPS11;RPLP2;RPL18;RPS4X;RPL9;RPS23;RPL5;RPL18A;RPS13;RPS3A;RPL7A;RPL15;RPL8;RPL36;RPS29;RPS24;RPL6;RPL12;FOS;RPL4;FAU;RPL10A;RPL7;RPL35;RPS21;RPS26;RPSA;RPS7;RPS3;RPL31;RPL21;RPL23A;RPL27A;RPS16;RPL23;RPL14;RPL24;RPL22;RPS5;RPS10;RPS25;RPS9;RPL26;UBA52;RPL38;RPL27;RPS20;RPL36A;JUN;RPL36AL;RPL17;RPS17;RPL41;RPLP1;RPL10;RPL13;RPS28;RPL37A;RPS2;RPS27;RPL37;RPL28;RPL29;RPS14;RPS18
prerank,MicroRNAs in cancer,0.9923600083890103,0.9991695383840066,0.5294117647058824,1.0,1.0,6/161,0.78%,VIM;TPM1;HNRNPK;MARCKS;RHOA;STMN1
prerank,Amyotrophic lateral sclerosis,0.9910213919855391,0.9991078743077838,0.52,1.0,1.0,35/348,0.99%,ACTB;ACTG1;HNRNPA1;ATP5F1E;TUBB;HNRNPA2B1;PFN1;TUBA1A;TUBA1B;COX7A2;COX5B;ATP5MC2;ATP5F1A;ATF4;NDUFA13;UQCRQ;TUBB4B;SRSF3;NDUFA11;ATP5F1B;COX8A;COX6A1;NDUFA4;UQCR11;COX6B1;COX7C;UQCRH;UQCRB;COX6C;HNRNPA3;COX4I1;FUS;NDUFB1;UQCR10;NDUFB2
prerank,Arrhythmogenic right ventricular cardiomyopathy,0.9934550670930336,0.9991027087049276,0.5454545454545454,1.0,1.0,5/77,0.67%,ACTB;ACTG1;CTNNB1;DES;ITGB1
prerank,ErbB signaling pathway,0.9934236092428183,0.9990702068950703,0.5285714285714286,1.0,1.0,1/85,0.66%,JUN
prerank,Rap1 signaling pathway,0.991928708593375,0.9990399907794134,0.5232558139534884,1.0,1.0,9/210,0.83%,ACTB;ACTG1;GNAS;PFN1;CTNNB1;RHOA;ITGB1;CALM1;CALM2
prerank,Kaposi sarcoma-associated herpesvirus infection,0.9919328235117711,0.9990096818083135,0.5882352941176471,1.0,1.0,9/193,0.83%,RPS27A;FOS;UBB;UBA52;UBC;CTNNB1;JUN;CALM1;CALM2
prerank,Cocaine addiction,0.9934903998327806,0.99896018849349,0.5263157894736842,1.0,1.0,3/49,0.66%,GNAS;ATF4;JUN
prerank,Vasopressin-regulated water reabsorption,0.9925359765928226,0.9989228368388496,0.4782608695652174,1.0,1.0,2/44,0.75%,GNAS;DYNLL1
prerank,Pyruvate metabolism,0.9919082738646203,0.9989133926069693,0.5,1.0,1.0,1/47,0.81%,LDHB
prerank,Herpes simplex virus 1 infection,0.9899530942653957,0.998870537087065,0.7070707070707071,1.0,1.0,4/493,1.00%,CALR;SRSF2;SRSF3;B2M
prerank,Alzheimer disease,0.9909290901967879,0.9988605541212496,0.57,1.0,1.0,32/355,0.99%,GAPDH;ATP5F1E;TUBB;TUBA1A;TUBA1B;COX7A2;COX5B;ATP5MC2;CTNNB1;ATP5F1A;ATF4;NDUFA13;UQCRQ;TUBB4B;NDUFA11;ATP5F1B;COX8A;COX6A1;NDUFA4;UQCR11;COX6B1;COX7C;UQCRH;CALM1;CALM2;UQCRB;SLC25A6;COX6C;COX4I1;NDUFB1;UQCR10;NDUFB2
prerank,cAMP signaling pathway,0.9918672348598522,0.9988593622647999,0.5463917525773195,1.0,1.0,7/216,0.83%,FOS;GNAS;MYL9;RHOA;JUN;CALM1;CALM2
prerank,Renal cell carcinoma,0.9934566315097553,0.9987761948931645,0.603448275862069,1.0,1.0,2/69,0.66%,ELOB;JUN
prerank,Phenylalanine metabolism,0.9936756063363265,0.9987506496621757,0.6666666666666666,1.0,1.0,1/17,0.64%,MIF
prerank,Cytosolic DNA-sensing pathway,0.9929802551005168,0.9987423194145357,0.5813953488372093,1.0,1.0,1/61,0.70%,POLR2L
prerank,Ras signaling pathway,0.9917434773471041,0.9987242758217104,0.5376344086021505,1.0,1.0,3/231,0.83%,RHOA;CALM1;CALM2
prerank,Leukocyte transendothelial migration,0.9919818094782189,0.9987024053457403,0.631578947368421,1.0,1.0,8/114,0.82%,ACTB;ACTG1;MYL9;MYL12B;CTNNB1;RHOA;ITGB1;MMP2
prerank,Apelin signaling pathway,0.9918567750434104,0.9986984299119195,0.6075949367088608,1.0,1.0,6/136,0.83%,RPS6;ACTA2;EGR1;MYLK;CALM1;CALM2
prerank,Huntington disease,0.9908259640257476,0.9986871911606949,0.6458333333333334,1.0,1.0,28/292,0.99%,ATP5F1E;TUBB;TUBA1A;TUBA1B;COX7A2;COX5B;ATP5MC2;ATP5F1A;NDUFA13;UQCRQ;TUBB4B;NDUFA11;ATP5F1B;COX8A;POLR2L;COX6A1;NDUFA4;UQCR11;COX6B1;COX7C;UQCRH;UQCRB;SLC25A6;COX6C;COX4I1;NDUFB1;UQCR10;NDUFB2
prerank,Calcium signaling pathway,0.991170906033214,0.9986645515499807,0.6041666666666666,1.0,1.0,5/239,0.89%,GNAS;MYLK;CALM1;CALM2;SLC25A6
prerank,Oxytocin signaling pathway,0.9920321111909899,0.9986336120222509,0.5930232558139535,1.0,1.0,12/154,0.83%,ACTB;ACTG1;MYL6;FOS;GNAS;MYL9;EEF2;RHOA;MYLK;JUN;CALM1;CALM2
prerank,Tuberculosis,0.991757088903543,0.9986289314241187,0.6463414634146342,1.0,1.0,3/176,0.83%,RHOA;CALM1;CALM2
prerank,GnRH signaling pathway,0.9918971445657047,0.9985752127147215,0.6363636363636364,1.0,1.0,7/93,0.83%,GNAS;ATF4;EGR1;JUN;CALM1;MMP2;CALM2
prerank,Adrenergic signaling in cardiomyocytes,0.9918833113693541,0.9985745887551499,0.6103896103896104,1.0,1.0,7/150,0.83%,GNAS;TPM1;TPM2;ATF4;TPM4;CALM1;CALM2
prerank,Dopaminergic synapse,0.9918278153625095,0.9985607290737862,0.5853658536585366,1.0,1.0,5/132,0.83%,FOS;GNAS;ATF4;CALM1;CALM2
prerank,Toxoplasmosis,0.9917135335646763,0.9985081993100797,0.6571428571428571,1.0,1.0,3/110,0.83%,LAMB1;ITGB1;HSPA8
prerank,Glucagon signaling pathway,0.9918341708542711,0.9984878477950069,0.6811594202898551,1.0,1.0,5/106,0.83%,GNAS;ATF4;LDHB;CALM1;CALM2
prerank,Small cell lung cancer,0.992405668839323,0.9984082369300864,0.639344262295082,1.0,1.0,5/92,0.77%,FN1;LAMB1;ITGB1;COL4A1;COL4A2
prerank,Cysteine and methionine metabolism,0.9919075489727663,0.9983991448166271,0.6304347826086957,1.0,1.0,1/50,0.81%,LDHB
prerank,Longevity regulating pathway,0.9916856083263548,0.9983754907518706,0.671875,1.0,1.0,2/102,0.83%,ATF4;HSPA8
prerank,Inflammatory mediator regulation of TRP channels,0.9917763157894735,0.9983703871442545,0.6716417910447762,1.0,1.0,3/98,0.83%,GNAS;CALM1;CALM2
prerank,Aldosterone synthesis and secretion,0.9918062200956936,0.9983323167252034,0.625,1.0,1.0,4/98,0.83%,GNAS;ATF4;CALM1;CALM2
prerank,Measles,0.991736279529327,0.9983148856915979,0.7051282051282052,1.0,1.0,4/139,0.83%,FOS;RACK1;JUN;HSPA8
prerank,Salmonella infection,0.9907476944335973,0.9983088299192601,0.6559139784946236,1.0,1.0,23/249,0.99%,ACTB;ACTG1;FOS;GAPDH;RPS3;FLNA;MYL9;TUBB;PFN1;S100A10;TUBA1A;TUBA1B;ARF1;MYL12B;CTNNB1;RHOA;HSP90B1;TUBB4B;JUN;DYNLL1;TXN;HSP90AB1;HSP90AA1
prerank,Ribosome,0.9917676994461904,0.9982212410335374,0.611764705882353,1.0,1.0,80/133,1.06%,RPS8;RPS12;RPL34;RPL11;RPL32;RPL13A;RPS15A;RPS19;RPL30;RPS27A;RPL19;RPLP0;RPL39;RPS15;RPL35A;RPL3;RPS6;RPS11;RPLP2;RPL18;RPS4X;RPL9;RPS23;RPL5;RPL18A;RPS13;RPS3A;RPL7A;RPL15;RPL8;RPL36;RPS29;RPS24;RPL6;RPL12;RPL4;FAU;RPL10A;RPL7;RPL35;RPS21;RPS26;RPSA;RPS7;RPS3;RPL31;RPL21;RPL23A;RPL27A;RPS16;RPL23;RPL14;RPL24;RPL22;RPS5;RPS10;RPS25;RPS9;RPL26;UBA52;RPL38;RPL27;RPS20;RPL36A;RPL36AL;RPL17;RPS17;RPL41;RPLP1;RPL10;RPL13;RPS28;RPL37A;RPS2;RPS27;RPL37;RPL28;RPL29;RPS14;RPS18
prerank,Prion disease,0.9908951591093491,0.9982203769232125,0.6631578947368421,1.0,1.0,30/259,0.99%,ATP5F1E;TUBB;TUBA1A;TUBA1B;COX7A2;COX5B;ATP5MC2;ATP5F1A;ATF4;NDUFA13;UQCRQ;EGR1;TUBB4B;NDUFA11;ATP5F1B;COX8A;COX6A1;NDUFA4;UQCR11;COX6B1;COX7C;UQCRH;HSPA8;UQCRB;SLC25A6;COX6C;COX4I1;NDUFB1;UQCR10;NDUFB2
prerank,C-type lectin receptor signaling pathway,0.9918047496560389,0.998170583060405,0.676056338028169,1.0,1.0,4/104,0.83%,RHOA;JUN;CALM1;CALM2
prerank,Renin secretion,0.991783441393528,0.9981487243717294,0.7608695652173914,1.0,1.0,3/69,0.83%,GNAS;CALM1;CALM2
prerank,HIF-1 signaling pathway,0.9920129229112447,0.9981417851219244,0.6578947368421053,1.0,1.0,5/109,0.81%,RPS6;GAPDH;ELOB;ENO1;LDHB
prerank,Parkinson disease,0.9911119118397757,0.9981397474907768,0.7052631578947368,1.0,1.0,37/235,0.99%,RPS27A;GNAS;ATP5F1E;TUBB;UBB;UBA52;UBC;TUBA1A;TUBA1B;COX7A2;COX5B;ATP5MC2;ATP5F1A;ATF4;NDUFA13;UQCRQ;TUBB4B;NDUFA11;ATP5F1B;COX8A;COX6A1;NDUFA4;UQCR11;COX6B1;COX7C;UQCRH;TXN;CALM1;CALM2;DUSP1;UQCRB;SLC25A6;COX6C;COX4I1;NDUFB1;UQCR10;NDUFB2
prerank,Propanoate metabolism,0.9919116549768692,0.9981071049885167,0.6111111111111112,1.0,1.0,1/33,0.81%,LDHB
prerank,Thermogenesis,0.9908760767129879,0.9980563233387559,0.7159090909090909,1.0,1.0,29/219,0.99%,ACTB;ACTG1;RPS6;GNAS;ATP5F1E;ATP5ME;COX7A2;COX5B;ATP5MC2;ATP5F1A;NDUFA13;ATP5MF;UQCRQ;NDUFA11;ATP5F1B;COX8A;COX6A1;NDUFA4;UQCR11;COX6B1;COX7C;UQCRH;ATP5MG;UQCRB;COX6C;COX4I1;NDUFB1;UQCR10;NDUFB2
prerank,Glycolysis / Gluconeogenesis,0.9919933078393881,0.9980462292223992,0.6851851851851852,1.0,1.0,4/66,0.81%,GAPDH;TPI1;ENO1;LDHB
prerank,PI3K-Akt signaling pathway,0.9901166119263566,0.9979920419281733,0.7959183673469388,1.0,1.0,16/351,1.03%,COL1A2;RPS6;FN1;COL6A1;COL6A2;ATF4;HSP90B1;COL6A3;LAMB1;ITGB1;COL4A1;COL4A2;HSP90AB1;YWHAZ;HSP90AA1;COL1A1
prerank,Melanogenesis,0.9918054849418307,0.997988154426601,0.6666666666666666,1.0,1.0,4/101,0.83%,GNAS;CTNNB1;CALM1;CALM2
prerank,cGMP-PKG signaling pathway,0.9912801150665227,0.9979876571735736,0.6818181818181818,1.0,1.0,8/166,0.89%,MYL9;ATF4;RHOA;GTF2I;MYLK;CALM1;CALM2;SLC25A6
prerank,Insulin signaling pathway,0.9917669600622717,0.997962154183018,0.6962025316455697,1.0,1.0,3/136,0.83%,RPS6;CALM1;CALM2
prerank,Retinol metabolism,0.9921123394084255,0.997941660543112,0.6862745098039216,1.0,1.0,1/68,0.79%,CYP2W1
prerank,Fatty acid degradation,0.9913718465442604,0.9979295280304576,0.6052631578947368,1.0,1.0,1/43,0.86%,ACADVL
prerank,Phosphatidylinositol signaling system,0.9917469050894085,0.9979141896253017,0.7741935483870968,1.0,1.0,2/96,0.83%,CALM1;CALM2
prerank,Spinocerebellar ataxia,0.9910765084593502,0.997908323209291,0.7066666666666667,1.0,1.0,1/143,0.89%,SLC25A6
prerank,Circadian entrainment,0.9918064651176697,0.9978952379814636,0.6911764705882353,1.0,1.0,4/97,0.83%,FOS;GNAS;CALM1;CALM2
prerank,Human papillomavirus infection,0.990002409058058,0.9978581786854129,0.8383838383838383,1.0,1.0,12/330,1.03%,COL1A2;GNAS;FN1;COL6A1;COL6A2;CTNNB1;COL6A3;LAMB1;ITGB1;COL4A1;COL4A2;COL1A1
prerank,Amphetamine addiction,0.9918730765783264,0.9978552926336395,0.7719298245614035,1.0,1.0,6/69,0.83%,FOS;GNAS;ATF4;JUN;CALM1;CALM2
prerank,Hepatitis C,0.9908930229771427,0.9978530738250987,0.7380952380952381,1.0,1.0,3/157,0.92%,CD81;CTNNB1;YWHAZ
prerank,Protein processing in endoplasmic reticulum,0.9903506143242433,0.9978242936502663,0.7023809523809523,1.0,1.0,9/168,0.99%,CALR;P4HB;ATF4;HSP90B1;SSR4;HSPA8;HSP90AB1;SEC61G;HSP90AA1
prerank,Alcoholism,0.9918042593921989,0.9978220787941258,0.6865671641791045,1.0,1.0,4/106,0.83%,GNAS;ATF4;CALM1;CALM2
prerank,Pertussis,0.9919012611320304,0.9978110279149988,0.6779661016949152,1.0,1.0,7/76,0.83%,FOS;CFL1;RHOA;JUN;ITGB1;CALM1;CALM2
prerank,Serotonergic synapse,0.9912942021181115,0.9978088509741302,0.7105263157894737,1.0,1.0,2/112,0.87%,GNAS;DUSP1
prerank,Influenza A,0.9911292256053704,0.9977832386350048,0.6951219512195121,1.0,1.0,3/170,0.89%,ACTB;ACTG1;SLC25A6
prerank,Gastric acid secretion,0.9918713764867609,0.9977650465101948,0.7213114754098361,1.0,1.0,6/76,0.83%,ACTB;ACTG1;GNAS;MYLK;CALM1;CALM2
prerank,Viral carcinogenesis,0.9909507685853832,0.997737283533458,0.6976744186046512,1.0,1.0,5/165,0.92%,ATF4;HNRNPK;RHOA;JUN;YWHAZ
prerank,Cell cycle,0.9908421619680373,0.9976710848611908,0.7714285714285715,1.0,1.0,1/124,0.92%,YWHAZ
prerank,Salivary secretion,0.9918074450590522,0.997664781161852,0.7321428571428571,1.0,1.0,4/93,0.83%,GNAS;CST3;CALM1;CALM2
prerank,Epstein-Barr virus infection,0.9900416929122047,0.9976473449511055,0.813953488372093,1.0,1.0,4/199,1.00%,VIM;CALR;JUN;B2M
prerank,RNA polymerase,0.9929869587275061,0.9976244182223214,0.7,1.0,1.0,1/29,0.70%,POLR2L
prerank,Pathogenic Escherichia coli infection,0.9904924719572907,0.9975977037217726,0.7526881720430108,1.0,1.0,15/196,0.99%,ACTB;ACTG1;FOS;GAPDH;RPS3;TUBB;TUBA1A;TUBA1B;ARF1;RHOA;TUBB4B;JUN;ITGB1;MYH11;MYH9
prerank,Vascular smooth muscle contraction,0.9904208824762019,0.9975878912138935,0.7831325301204819,1.0,1.0,12/132,0.99%,MYL6;ACTG2;GNAS;ACTA2;MYL9;RHOA;CALD1;MYLK;CALM1;CALM2;MYH11;MYH9
prerank,Glioma,0.9917520843917162,0.9975831143915177,0.7368421052631579,1.0,1.0,2/75,0.83%,CALM1;CALM2
prerank,Long-term potentiation,0.9917839323593558,0.9975771280891612,0.8035714285714286,1.0,1.0,3/67,0.83%,ATF4;CALM1;CALM2
prerank,Lipid and atherosclerosis,0.9903973112471487,0.9975416045333476,0.7789473684210526,1.0,1.0,11/214,0.99%,FOS;ATF4;RHOA;HSP90B1;JUN;CALM1;CALM2;HSPA8;HSP90AB1;APOA1;HSP90AA1
prerank,Bladder cancer,0.9917903095799624,0.9975411613592008,0.7222222222222222,1.0,1.0,1/41,0.82%,MMP2
prerank,Regulation of actin cytoskeleton,0.990426170468187,0.9975405147140078,0.8172043010752689,1.0,1.0,13/218,0.99%,ACTB;ACTG1;TMSB4X;MYL9;CFL1;FN1;PFN1;MYL12B;RHOA;MYLK;ITGB1;MYH11;MYH9
prerank,Phagosome,0.9907756813417192,0.9975278062047175,0.7560975609756098,1.0,1.0,9/148,0.95%,ACTB;ACTG1;TUBB;TUBA1A;TUBA1B;CALR;TUBB4B;ITGB1;SEC61G
prerank,Chemical carcinogenesis,0.9903349741865769,0.9974984031333965,0.7446808510638298,1.0,1.0,9/222,0.99%,FOS;GNAS;GSTP1;ATF4;HSP90B1;JUN;HSP90AB1;GSTA1;HSP90AA1
prerank,Diabetic cardiomyopathy,0.9905241693654798,0.9974746175577837,0.7654320987654321,1.0,1.0,28/190,1.03%,COL1A2;GAPDH;ATP5F1E;COX7A2;COX5B;ATP5MC2;ATP5F1A;NDUFA13;UQCRQ;NDUFA11;ATP5F1B;COX8A;COX6A1;NDUFA4;UQCR11;COX6B1;COX7C;UQCRH;MMP2;UQCRB;SLC25A6;COX6C;COX4I1;NDUFB1;UQCR10;NDUFB2;COL3A1;COL1A1
prerank,Transcriptional misregulation in cancer,0.9903788514566598,0.9974570360886446,0.7816091954022989,1.0,1.0,2/174,0.96%,DDX5;FUS
prerank,Neurotrophin signaling pathway,0.9912325323917532,0.997443853896841,0.7162162162162162,1.0,1.0,7/119,0.89%,MAGED1;ATF4;RHOA;JUN;CALM1;CALM2;BEX3
prerank,Central carbon metabolism in cancer,0.9919027130393211,0.9974330614653658,0.7169811320754716,1.0,1.0,1/70,0.81%,LDHB
prerank,Human cytomegalovirus infection,0.9901548805378797,0.9974095083798078,0.8333333333333334,1.0,1.0,8/222,1.00%,GNAS;CALR;CTNNB1;ATF4;RHOA;CALM1;CALM2;B2M
prerank,Tight junction,0.9904105483967633,0.9974070573135726,0.8390804597701149,1.0,1.0,12/168,0.99%,ACTB;ACTG1;MYL6;MYL9;TUBA1A;TUBA1B;MYL12B;RHOA;JUN;ITGB1;MYH11;MYH9
prerank,Non-alcoholic fatty liver disease,0.9906550453769432,0.9973616544842296,0.8,1.0,1.0,21/151,0.99%,FOS;COX7A2;COX5B;ATF4;NDUFA13;UQCRQ;JUN;NDUFA11;COX8A;COX6A1;NDUFA4;UQCR11;COX6B1;COX7C;UQCRH;UQCRB;COX6C;COX4I1;NDUFB1;UQCR10;NDUFB2
prerank,Human T-cell leukemia virus 1 infection,0.9901263467482968,0.9973574564032422,0.8275862068965517,1.0,1.0,7/217,1.00%,FOS;CALR;ATF4;EGR1;JUN;SLC25A6;B2M
prerank,Human immunodeficiency virus 1 infection,0.9901584253480556,0.9973510250496844,0.8241758241758241,1.0,1.0,8/210,1.00%,FOS;CFL1;CALR;ELOB;JUN;CALM1;CALM2;B2M
prerank,Fc gamma R-mediated phagocytosis,0.9904909993421447,0.9973406534460563,0.8153846153846154,1.0,1.0,3/96,0.96%,CFL1;MARCKS;MARCKSL1
prerank,Hepatocellular carcinoma,0.9905609492988133,0.9973270187447182,0.7317073170731707,1.0,1.0,5/166,0.95%,ACTB;ACTG1;GSTP1;CTNNB1;GSTA1
prerank,Cellular senescence,0.9911928584266969,0.9973062424768192,0.7307692307692307,1.0,1.0,5/156,0.89%,ZFP36L1;CALM1;CALM2;ZFP36L2;SLC25A6
prerank,Hepatitis B,0.9909218923210593,0.9972886904371268,0.7529411764705882,1.0,1.0,4/161,0.92%,FOS;ATF4;JUN;YWHAZ
prerank,Hippo signaling pathway,0.9909218923210592,0.9972807131407929,0.7682926829268293,1.0,1.0,4/161,0.92%,ACTB;ACTG1;CTNNB1;YWHAZ
prerank,Spliceosome,0.9904200221536987,0.9972706662563666,0.7222222222222222,1.0,1.0,14/135,1.00%,HNRNPA1;HNRNPK;SRSF2;SNRPD2;HNRNPU;LSM7;DDX5;SRSF3;SNRNP70;HSPA8;HNRNPC;HNRNPA3;FUS;PCBP1
prerank,RNA transport,0.9900818026548406,0.9972399879430845,0.7692307692307693,1.0,1.0,7/165,1.01%,EIF1;EIF4G2;PABPC1;EIF4A1;FUS;EIF4A2;EEF1A1
prerank,Fat digestion and absorption,0.9908645808454739,0.9971714144076712,0.7352941176470589,1.0,1.0,2/42,0.92%,FABP1;APOA1
prerank,Oxidative phosphorylation,0.9907834101382487,0.997165631951243,0.7746478873239436,1.0,1.0,25/120,0.99%,ATP5F1E;ATP5ME;COX7A2;COX5B;ATP5MC2;ATP5F1A;NDUFA13;ATP5MF;UQCRQ;NDUFA11;ATP5F1B;COX8A;COX6A1;NDUFA4;UQCR11;COX6B1;COX7C;UQCRH;ATP5MG;UQCRB;COX6C;COX4I1;NDUFB1;UQCR10;NDUFB2
prerank,NOD-like receptor signaling pathway,0.9902577937649879,0.9971523376825374,0.8117647058823529,1.0,1.0,6/178,0.99%,RHOA;JUN;TXNIP;TXN;HSP90AB1;HSP90AA1
prerank,Mitophagy,0.9916342993725724,0.997088394717788,0.7755102040816326,1.0,1.0,7/68,0.86%,RPS27A;UBB;UBA52;UBC;ATF4;JUN;TOMM7
prerank,Focal adhesion,0.990251072382038,0.9970767593436691,0.8172043010752689,1.0,1.0,19/201,1.03%,ACTB;COL1A2;ACTG1;FLNA;MYL9;FN1;COL6A1;MYL12B;COL6A2;CTNNB1;RHOA;COL6A3;MYLK;LAMB1;JUN;ITGB1;COL4A1;COL4A2;COL1A1
prerank,Retrograde endocannabinoid signaling,0.990178758571129,0.9970674444698888,0.8333333333333334,1.0,1.0,5/141,0.99%,NDUFA13;NDUFA11;NDUFA4;NDUFB1;NDUFB2
prerank,Cardiac muscle contraction,0.9907039306531156,0.9970524990700472,0.8269230769230769,1.0,1.0,16/83,0.98%,TPM1;TPM2;COX7A2;COX5B;TPM4;UQCRQ;COX8A;COX6A1;UQCR11;COX6B1;COX7C;UQCRH;UQCRB;COX6C;COX4I1;UQCR10
prerank,Estrogen signaling pathway,0.990419448519505,0.9970382027853599,0.8513513513513513,0.9976218591058719,1.0,11/137,0.99%,FOS;GNAS;ATF4;HSP90B1;JUN;CALM1;MMP2;CALM2;HSPA8;HSP90AB1;HSP90AA1
prerank,Legionellosis,0.9899943251396315,0.9970149370848131,0.9782608695652174,0.9953505591199411,1.0,3/57,1.01%,ARF1;HSPA8;EEF1A1
prerank,Viral myocarditis,0.9912189002717959,0.9969805300435343,0.7872340425531915,0.9949769319642908,1.0,3/57,0.89%,ACTB;ACTG1;EIF4G2
prerank,Oocyte meiosis,0.9909017448298567,0.9969702024342187,0.7894736842105263,0.991086066038696,1.0,3/125,0.92%,CALM1;CALM2;YWHAZ
prerank,Neutrophil extracellular trap formation,0.9911755907867184,0.9969441288059239,0.75,0.9896842399704039,1.0,4/108,0.89%,ACTB;ACTG1;HMGB1;SLC25A6
prerank,Cholesterol metabolism,0.9908325370281892,0.9969297997382576,0.7441860465116279,0.986656306573319,1.0,1/50,0.92%,APOA1
prerank,Phototransduction,0.9917636526410027,0.9969013687371203,0.85,0.9848383960157818,1.0,2/28,0.83%,CALM1;CALM2
prerank,Glutathione metabolism,0.9905629386292367,0.9968977122656675,0.84,0.9795990518966818,1.0,4/53,0.95%,GSTP1;ANPEP;GPX4;GSTA1
prerank,Proteoglycans in cancer,0.9901007919366449,0.9968817033980435,0.8333333333333334,0.976355919068866,1.0,14/202,1.03%,ACTB;COL1A2;ACTG1;RPS6;FLNA;FN1;DCN;CTNNB1;RHOA;CD63;DDX5;ITGB1;MMP2;COL1A1
prerank,Antigen processing and presentation,0.9901102512773012,0.996874477379986,0.864406779661017,0.9722499801082987,1.0,5/69,1.00%,CALR;HSPA8;HSP90AB1;HSP90AA1;B2M
prerank,Drug metabolism,0.9904884395656988,0.9968637336225347,0.8289473684210527,0.9687005470200492,1.0,2/105,0.95%,GSTP1;GSTA1
prerank,Vitamin digestion and absorption,0.9908399224227957,0.9968603189894074,0.7727272727272727,0.9637296566184028,1.0,1/23,0.92%,APOA1
prerank,Progesterone-mediated oocyte maturation,0.9901620716464326,0.9968405390133221,0.8360655737704918,0.9617186951211848,1.0,2/96,0.99%,HSP90AB1;HSP90AA1
prerank,Necroptosis,0.9897021403981439,0.9968345133792638,0.9054054054054054,0.9571543518213813,1.0,7/133,1.05%,PPIA;HMGB1;HSP90AB1;SLC25A6;HSP90AA1;FTL;FTH1
prerank,RNA degradation,0.9907648166412624,0.9967811336242993,0.7666666666666667,0.9609484326469713,1.0,3/79,0.93%,LSM7;ENO1;PABPC1
prerank,TGF-beta signaling pathway,0.990252653610405,0.9966672621680516,0.8253968253968254,0.9729653955851107,1.0,4/93,0.98%,DCN;RHOA;FBN1;ID3
prerank,PPAR signaling pathway,0.99088572794645,0.9966656146658069,0.8260869565217391,0.968352404070514,1.0,3/74,0.92%,FABP1;UBC;APOA1
prerank,Platelet activation,0.9900041898605373,0.996646670504939,0.9178082191780822,0.9652025602721234,1.0,10/124,1.03%,ACTB;COL1A2;ACTG1;GNAS;MYL12B;RHOA;MYLK;ITGB1;COL3A1;COL1A1
prerank,Leishmaniasis,0.990049305244285,0.996640509953361,0.8939393939393939,0.9616582239518586,1.0,5/73,1.01%,FOS;JUN;ITGB1;MARCKSL1;EEF1A1
prerank,African trypanosomiasis,0.9908662169422722,0.99654325489965,0.8518518518518519,0.9693421934085834,1.0,2/36,0.92%,HBA2;APOA1
prerank,Protein export,0.9906012233328361,0.9965069729224741,0.875,0.9689593502653122,1.0,2/23,0.95%,SRP14;SEC61G
prerank,Fluid shear stress and atherosclerosis,0.9905694269804203,0.9965063397885735,0.8666666666666667,0.9640066300794939,1.0,16/136,0.99%,ACTB;ACTG1;FOS;GSTP1;CTNNB1;RHOA;HSP90B1;JUN;TXN;CALM1;MMP2;CALM2;HSP90AB1;DUSP1;GSTA1;HSP90AA1
prerank,Th17 cell differentiation,0.9902192444590673,0.9964944271162779,0.7971014492753623,0.9600634088445291,1.0,4/105,0.99%,FOS;JUN;HSP90AB1;HSP90AA1
prerank,Signaling pathways regulating pluripotency of stem cells,0.9901781703847881,0.9964819145812608,0.8648648648648649,0.9571139948668812,1.0,2/143,0.98%,CTNNB1;ID3
prerank,mRNA surveillance pathway,0.9904007177033493,0.9963897830861337,0.8333333333333334,0.9621940137510999,1.0,2/98,0.96%,PABPC1;FUS
prerank,IL-17 signaling pathway,0.9902523621576365,0.9963132994856917,0.9178082191780822,0.9657482250843247,1.0,5/94,0.99%,FOS;HSP90B1;JUN;HSP90AB1;HSP90AA1
prerank,Amoebiasis,0.9899811585967639,0.9963039657123594,0.9692307692307692,0.961817944627666,1.0,9/101,1.03%,COL1A2;GNAS;FN1;LAMB1;HSPB1;COL4A1;COL4A2;COL3A1;COL1A1
prerank,Vibrio cholerae infection,0.9907130912565694,0.9962364999449483,0.8974358974358975,0.9649878831798498,1.0,6/50,0.95%,ACTB;ACTG1;GNAS;ARF1;KDELR2;SEC61G
prerank,AGE-RAGE signaling pathway in diabetic complications,0.9899814582211851,0.9962338962504013,0.84375,0.9602883721140983,1.0,9/100,1.03%,COL1A2;FN1;EGR1;JUN;COL4A1;COL4A2;MMP2;COL3A1;COL1A1
prerank,Relaxin signaling pathway,0.9900326259391182,0.9961788909207728,0.8974358974358975,0.9623943988192618,1.0,11/129,1.03%,COL1A2;FOS;GNAS;ACTA2;ATF4;JUN;COL4A1;COL4A2;MMP2;COL3A1;COL1A1
prerank,Metabolism of xenobiotics by cytochrome P450,0.9904978186816473,0.9961587821610238,0.7868852459016393,0.9594216104070876,1.0,2/72,0.95%,GSTP1;GSTA1
prerank,Prostate cancer,0.9902813911067252,0.9960975711827081,0.8695652173913043,0.961225051148876,1.0,6/97,0.99%,GSTP1;CTNNB1;ATF4;HSP90B1;HSP90AB1;HSP90AA1
prerank,Protein digestion and absorption,0.9900403768506055,0.9959946983787725,0.9333333333333333,0.9660266239700117,1.0,11/103,1.03%,COL1A2;COL6A1;COL5A1;COL6A2;COL6A3;COL4A1;COL4A2;COL16A1;COL5A2;COL3A1;COL1A1
prerank,ECM-receptor interaction,0.9900149476831089,0.995955709565506,0.9830508474576272,0.9646653787446462,1.0,10/88,1.03%,COL1A2;FN1;COL6A1;COL6A2;COL6A3;LAMB1;ITGB1;COL4A1;COL4A2;COL1A1
prerank,Mineral absorption,0.98969472489396,0.9954533163750708,0.9803921568627451,0.9897444735435948,1.0,6/60,1.05%,MT1G;MT1H;MT1E;MT2A;FTL;FTH1
prerank,Ferroptosis,0.9896707167806076,0.9940849735874062,0.9767441860465116,0.9997757093192778,1.0,5/41,1.05%,PCBP2;GPX4;PCBP1;FTL;FTH1
prerank,Primary immunodeficiency,-0.03250649234351213,-0.9741886234330086,0.38666666666666666,1.0,1.0,37/37,100.00%,AIRE;IGLL1;CD79A;RFXANK;TNFRSF13C;CD40;ADA;TNFRSF13B;CD19;CIITA;ORAI1;UNG;RFXAP;CD4;JAK3;BLNK;DCLRE1C;CD3D;CD3E;AICDA;RAG2;RAG1;IKBKG;CD40LG;BTK;IL2RG;TAP1;TAP2;IL7R;ICOS;CD8B2;CD8B;CD8A;ZAP70;PTPRC;RFX5;LCK
prerank,Steroid biosynthesis,-0.05426934781311534,-0.94221582733813,0.4074074074074074,1.0,1.0,20/20,100.00%,LSS;CYP24A1;DHCR7;CYP27B1;SOAT2;LIPA;TM7SF2;SC5D;CYP2R1;CEL;SQLE;NSDHL;FDFT1;EBP;CYP51A1;MSMO1;LBR;HSD17B7;SOAT1;DHCR24
prerank,Porphyrin and chlorophyll metabolism,-0.03576546453307858,-0.9148324499146525,0.4411764705882353,1.0,1.0,42/42,100.00%,HMOX1;BLVRB;FECH;COX10;EARS2;HMOX2;MMAB;UROS;COX15;HMBS;HEPHL1;ALAD;FXN;ALAS2;HEPH;HCCS;GUSB;BLVRA;CP;CPOX;ALAS1;UGT1A1;UGT1A3;UGT1A4;UGT1A5;UGT1A6;UGT1A7;UGT1A9;UGT1A10;UGT1A8;UGT2A2;UGT2B4;UGT2B28;UGT2B11;UGT2B7;UGT2A3;UGT2B10;UGT2B15;UGT2B17;UGT2A1;PPOX;UROD
prerank,Aminoacyl-tRNA biosynthesis,-0.04929430370304061,-0.914305730699173,0.3924050632911392,1.0,1.0,25/25,100.00%,SARS2;FARSA;EARS2;CARS2;GATC;MTFMT;YARS2;PSTK;NARS2;QRSL1;RARS2;AARS2;VARS2;FARS2;HARS2;SEPSECS;GATB;LARS2;FARSB;MARS2;IARS2;DARS2;WARS2;TARS2;PARS2
prerank,Pyrimidine metabolism,-0.025625709336359836,-0.879506421166641,0.4339622641509434,1.0,1.0,56/56,100.00%,TYMP;UPB1;UCKL1;ENTPD6;CANT1;TK1;TYMS;NT5C;NME2;NME1-NME2;NME1;NT5C3B;NT5M;DHODH;DCTPP1;TK2;NME3;NME4;ENTPD5;PNP;DUT;ENTPD1;NT5C2;ENTPD8;RRM1;UCK1;NUDT2;RRM2B;DPYS;ENTPD4;CTPS2;UPP1;NT5C3A;ENPP1;ENPP3;AK9;NT5E;DCK;DPYD;UMPS;NME6;ENTPD3;DTYMK;UPP2;RRM2;CMPK2;CAD;NT5C1B;NT5C1B-RDH14;DCTD;UCK2;NME7;CTPS1;NT5C1A;CMPK1;CDA
prerank,Glycerophospholipid metabolism,-0.01994557579019766,-0.8634304207119743,0.4444444444444444,1.0,1.0,97/97,100.00%,AGPAT3;PISD;PLA2G3;CHKB;PLA2G6;PLA2G4C;MBOAT7;LPIN3;PLD3;PNPLA6;PLPP2;CRLS1;CDS2;GPCPD1;PGS1;PCYT2;PHOSPHO1;GPD1L;DGKE;PLD2;PLA2G10;PLA2G15;ADPRM;PEMT;LCAT;CDIPT;LPIN2;LPCAT2;LPCAT4;JMJD7-PLA2G4B;PLA2G4B;PLA2G4F;PLA2G4D;PLA2G4E;PLD4;CHPT1;DGKH;PLA2G1B;DGKA;GPD1;CHAT;LPCAT3;PLPP4;GPAM;PLA2G12B;CHKA;ETNK1;DGKZ;PNPLA7;AGPAT2;PTDSS2;PTDSS1;PLPP5;GPAT4;LYPLA1;TAZ;AGPAT5;DGKK;DGKI;PCYT1B;ACHE;DGKB;AGPAT4;AGPAT1;MBOAT1;PLPP1;LPCAT1;ETNPPL;PLA2G12A;CDS1;GPAT3;PCYT1A;DGKG;PLD1;DGKQ;PLA1A;DGKD;GPD2;GPAT2;MBOAT2;SELENOI;LPIN1;GNPAT;LPGAT1;PLA2G4A;ETNK2;CEPT1;PLPP3;PLB1;LCLAT1;PLA2G2C;PLA2G5;PLA2G2A;PLA2G2E;PLA2G2D;PLA2G2F;LYPLA2
prerank,DNA replication,-0.037938033550235804,-0.8610922918897653,0.532258064516129,1.0,1.0,36/36,100.00%,MCM5;LIG1;POLD1;RNASEH2A;PCNA;RPA1;POLD3;POLE2;RNASEH2B;RFC5;RFC3;POLE;PRIM1;DNA2;RNASEH2C;POLA2;POLD4;FEN1;POLE3;MCM7;MCM4;RPA4;SSBP1;POLA1;RFC2;POLD2;RPA3;MCM3;PRIM2;RFC1;RFC4;MCM2;MCM6;POLE4;RNASEH1;RPA2
prerank,Arachidonic acid metabolism,-0.022311827956989248,-0.8454434333831319,0.5,1.0,1.0,58/58,100.00%,PLA2G3;CBR3;CBR1;PLA2G6;GGT5;GGT1;PLA2G4C;CYP2B6;PTGIS;ALOX12;ALOX15;PLA2G10;ALOX12B;ALOX15B;JMJD7-PLA2G4B;PLA2G4B;PLA2G4F;PLA2G4D;PLA2G4E;GPX2;LTA4H;PLA2G1B;PTGES3;ALOX5;CYP2E1;CYP2C9;CYP4F2;CYP4F3;CYP4F8;CYP2C19;CYP2C8;PLA2G12B;AKR1C3;PTGDS;PTGES;PTGS1;PTGES2;GPX3;EPHX2;TBXAS1;GPX5;GPX6;LTC4S;GPX8;PLA2G12A;CYP2U1;HPGDS;PLA2G4A;PTGS2;CYP2J2;GPX7;PLB1;PLA2G2C;PLA2G5;PLA2G2A;PLA2G2E;PLA2G2D;PLA2G2F
prerank,Ascorbate and aldarate metabolism,-0.03993076280291274,-0.8409730705901102,0.4507042253521127,1.0,1.0,30/30,100.00%,MIOX;ALDH3A2;ALDH2;KL;ALDH1B1;RGN;GUSB;ALDH7A1;UGDH;UGT1A1;UGT1A3;UGT1A4;UGT1A5;UGT1A6;UGT1A7;UGT1A9;UGT1A10;UGT1A8;UGT2A2;UGT2B4;UGT2B28;UGT2B11;UGT2B7;UGT2A3;UGT2B10;UGT2B15;UGT2B17;UGT2A1;ALDH9A1;AKR1A1
prerank,Neuroactive ligand-receptor interaction,-0.012139651173298793,-0.8191056910569107,1.0,1.0,1.0,341/341,100.00%,FPR3;FPR2;FPR1;GRIK1;GALR3;SSTR3;ADORA2A;PTGIR;GRIN2D;C5AR1;GIPR;P2RX6;PTH2;LHB;GRIK5;GHRH;S1PR5;S1PR2;P2RY11;LPAR2;RLN3;HRH3;EDN3;MC3R;KISS1R;C3;TSPO;MCHR1;NPBWR2;OPRL1;CHRNA4;NTSR1;SSTR4;S1PR4;TBXA2R;GRIN3B;GNRH2;OXT;AVP;ADRA1D;PDYN;MC4R;GRP;ADCYAP1;GALR2;HRH4;MC5R;MC2R;GALR1;NPB;GCGR;UTS2R;GIP;SSTR2;CRHR1;GRIN2C;THRB;HRH1;TAC4;PYY;PPY;THRA;HCRT;CSH2;GH2;CSH1;GH1;CHRNE;P2RX5;TRPV1;CHRNB1;GRIN2A;GLP2R;P2RX1;MC1R;ADORA2B;NPW;SSTR5;CHRNB4;CHRNA3;CHRNA5;CHRNA7;CHRM5;NMB;BDKRB1;BDKRB2;GABRG3;GABRA5;GABRB3;GRM5;P2RY6;P2RY2;PTGER2;PTGDR;TSHR;CTSG;SSTR1;LTB4R2;LTB4R;PMCH;HTR2A;LPAR6;CYSLTR2;MLNR;EDNRB;P2RX7;P2RX4;RXFP2;AVPR1A;NTS;P2RX2;TAC3;NPY4R2;NPY4R;IAPP;GRIN2B;NPFF;GRID1;PRLHR;ADRA2A;ADRB1;F2RL3;INSL3;PTGER1;HTR7;NPFFR1;TACR2;PARD3;GRIA4;UCN3;CALCA;CALCB;CCKBR;DRD2;GAL;MTNR1B;GPR83;GRIK4;FSHB;F2;CHRM4;C3AR1;GRIN1;PTH;ADM;CHRM1;P2RX3;DRD4;SCT;CHRNA10;APLNR;GABBR2;C5;LPAR1;GRIN3A;S1PR3;PRSS3;RLN1;RLN2;SLURP2;TRHR;ADRB3;CRH;CHRNA6;CHRNB3;NPBWR1;PENK;SLURP1;OPRK1;ADRA1A;GABRA3;GABRQ;GPR50;GABRE;GNRH1;CHRNA2;AVPR2;BRS3;APLN;GRIA3;HTR2C;P2RY10;LPAR4;CYSLTR1;P2RY4;GLRA2;GRPR;P2RY8;HTR5A;VIPR2;LEP;CHRM2;PRSS1;PRSS2;GRM8;TAC1;CALCR;GRM3;ADCYAP1R1;GHRHR;CRHR2;NPY;MAS1;PLG;OPRM1;VIP;GRM1;NMBR;TAAR2;TAAR5;TAAR6;TAAR8;TAAR9;TAAR1;GRIK2;MCHR2;GABRR1;CNR1;GABRR2;CGA;HTR1E;HTR1B;HCRTR2;GLP1R;GRM4;MLN;GABBR1;PRL;EDN1;PRLR;GRM6;HRH2;DRD1;GABRP;ADRA1B;GABRG2;GABRA1;GABRA6;GABRB2;GRIA1;NMUR2;GLRA1;NR3C1;ADRB2;HTR4;RXFP3;F2RL1;F2R;F2RL2;HTR1A;GHR;PTGER4;GZMA;MTNR1A;RXFP1;GLRB;GRIA2;GLRA3;EDNRA;NPY5R;NPY1R;AGTR1;P2RY13;P2RY14;TACR3;CHRNA9;GRID2;NPFFR2;NPY2R;NMU;CCKAR;GABRB1;GABRA4;GABRA2;GABRG1;DRD5;SST;GHSR;KNG1;UTS2B;P2RY1;TRH;ADRA2C;GNRHR;DRD3;GPR156;UCN2;GABRR3;GRM2;PTH1R;PRLH;CHRNG;CHRND;NMUR1;HTR2B;GPR35;VIPR1;CCK;HTR1F;OXTR;GRM7;GHRL;CHRNA1;CALCRL;PTH2R;GCG;SCTR;ADRA2B;TACR1;UCN;FSHR;LHCGR;NTSR2;POMC;AGT;CHRM3;AGTR2;AVPR1B;ADORA1;KISS1;RXFP4;TSHB;S1PR1;INSL5;LEPR;ADORA3;CHRNB2;PTGER3;LPAR3;PTGFR;HCRTR1;OPRD1;PTAFR;EDN2;GRIK3;HTR6;GABRD;CNR2;HTR1D;UTS2;CORT
prerank,Lysine degradation,-0.020612397311426438,-0.7866148068669524,0.45098039215686275,1.0,1.0,63/63,100.00%,KMT5C;KMT2B;GCDH;DOT1L;EZH1;PIPOX;ALDH3A2;PRDM7;SETD1A;DLST;HYKK;ALDH2;SETDB2;SETD1B;KMT5A;KMT2D;ECHS1;COLGALT1;DHTKD1;SUV39H2;ACAT1;KMT2A;KMT5B;BBOX1;EHMT1;ALDH1B1;NSD3;TMLHE;SUV39H1;KMT2C;EZH2;DLD;KMT2E;PLOD3;AASS;ACAT2;EHMT2;PHYKPL;NSD1;PRDM6;ALDH7A1;PRDM9;AADAT;HADH;SETD7;EHHADH;PLOD2;MECOM;NSD2;SETD2;SETMAR;COLGALT2;HADHA;CAMKMT;SMYD1;SMYD3;SMYD2;ALDH9A1;ASH1L;SETDB1;PRDM16;PRDM2;PLOD1
prerank,Pentose and glucuronate interconversions,-0.03993433815848381,-0.7705250507023214,0.42028985507246375,1.0,1.0,33/33,100.00%,DHDH;DCXR;SORD;KL;CRYL1;RPEL1;AKR1B10;AKR1B1;GUSB;UGDH;XYLB;UGT1A1;UGT1A3;UGT1A4;UGT1A5;UGT1A6;UGT1A7;UGT1A9;UGT1A10;UGT1A8;RPE;UGT2A2;UGT2B4;UGT2B28;UGT2B11;UGT2B7;UGT2A3;UGT2B10;UGT2B15;UGT2B17;UGT2A1;UGP2;AKR1A1
prerank,Mucin type O-glycan biosynthesis,-0.030625037311205302,-0.7593732157584214,0.5714285714285714,1.0,1.0,36/36,100.00%,B4GALT5;GALNT1;ST6GALNAC1;ST6GALNAC2;ST3GAL2;GALNT16;GCNT3;GALNT9;GALNT4;POC1B-GALNT4;GALNT6;GALNT8;B3GNT3;B3GNT6;GALNT18;GALNT12;ST6GALNAC4;GCNT1;ST3GAL1;C1GALT1C1;GALNT11;GALNTL5;GALNT17;C1GALT1;GALNT10;GCNT4;GALNT7;GALNTL6;GALNT15;GALNT3;GALNT13;GALNT5;C1GALT1C1L;GALNT2;ST6GALNAC3;GALNT14
prerank,Selenocompound metabolism,-0.04826680985621383,-0.7556775059840038,0.55,1.0,1.0,16/16,100.00%,TXNRD2;SEPHS2;TXNRD1;PSTK;PAPSS2;SEPHS1;KYAT1;INMT;PAPSS1;SEPSECS;TXNRD3;SCLY;MARS2;MTR;KYAT3;CTH
prerank,Proteasome,-0.02645407858593097,-0.729427320468522,0.5454545454545454,1.0,1.0,46/46,100.00%,PSMC4;PSMD8;ADRM1;PSMA7;PSMF1;PSMA8;PSMD12;PSME3;PSMD11;PSMD3;PSMC5;PSMB3;PSMB6;PSMB10;PSMD7;PSMA4;PSMC6;PSMC1;PSMA3;PSME2;PSME1;PSMB5;PSMA6;PSMB11;PSMD9;POMP;IFNG;PSMC3;PSMD13;PSMA1;PSMB7;PSMC2;SEM1;PSMA2;PSMB1;PSMB8;PSMB9;PSMD2;PSMD6;PSMD1;PSMD14;PSME4;PSMB4;PSMD4;PSMA5;PSMB2
prerank,Ether lipid metabolism,-0.022303833751343604,-0.718199002705081,0.6101694915254238,1.0,1.0,46/46,100.00%,PLA2G3;GAL3ST1;PLA2G6;PLA2G4C;TMEM86B;PAFAH1B3;PLD3;PLPP2;GDPD1;PLD2;PLA2G10;PAFAH1B1;GDPD3;LPCAT2;LPCAT4;JMJD7-PLA2G4B;PLA2G4B;PLA2G4F;PLA2G4D;PLA2G4E;PLD4;CHPT1;PLA2G1B;PLA2G12B;PAFAH1B2;ENPP2;PLA2G7;PLPP1;LPCAT1;ENPP6;UGT8;PLA2G12A;PLD1;AGPS;SELENOI;PLA2G4A;CEPT1;PLPP3;PLB1;PAFAH2;PLA2G2C;PLA2G5;PLA2G2A;PLA2G2E;PLA2G2D;PLA2G2F
prerank,Systemic lupus erythematosus,-0.01875354615223818,-0.704852854452413,0.6101694915254238,1.0,1.0,51/51,100.00%,SNRPD3;ACTN4;C3;ELANE;CD40;SNRPB;SNRPD1;GRIN2A;ACTN1;CTSG;IFNG;GRIN2B;C1R;C1S;TRIM21;C8G;C5;CD40LG;TNF;C2;HLA-DPB1;HLA-DPA1;HLA-DOA;HLA-DRB1;HLA-DMB;HLA-DOB;HLA-DQA2;HLA-DQB1;HLA-DQA1;HLA-DMA;C4B;C4A;HLA-DRA;HLA-DRB5;C6;C7;C9;CD86;CD80;CD28;SSB;IL10;FCGR3A;FCGR3B;FCGR2A;FCGR1A;C8A;C8B;C1QB;C1QC;C1QA
prerank,FoxO signaling pathway,-0.01158370498967344,-0.6910257258117851,0.8518518518518519,1.0,1.0,129/129,100.00%,MAPK11;MAPK12;CSNK1E;TPTEP2-CSNK1E;MAPK1;PRMT1;SGK2;CDKN2D;HOMER3;PIK3R2;TGFB1;AKT2;PCK1;INSR;MAP2K2;EP300;STK4;S1PR4;GADD45B;STK11;SMAD4;GRB2;RAF1;TGFBR2;G6PC3;STAT3;NLK;USP7;GABARAP;SLC2A4;GABARAPL2;MAPK3;PLK1;RBL2;CREBBP;PDPK1;IGF1R;TGFB3;HOMER2;SMAD3;MAP2K1;CCNB2;AKT1;SOS2;IRS2;FOXG1;IGF1;PCK2;PRKAB1;FOXO1;MDM2;AGAP2;CDK2;MAPK8;PRKAG1;BNIP3;KRAS;CDKN1B;CCND2;KLF2;PTEN;SIRT1;CHUK;ATM;CCND1;CAT;GABARAPL1;RAG2;RAG1;INS;HRAS;TGFBR1;GADD45G;CDKN2B;FBXO32;SGK3;IKBKB;FBXO25;FOXO4;CCNB3;ARAF;PRKAG2;BRAF;EGFR;IL6;SOD2;GRM1;SGK1;FOXO3;CDKN1A;MAPK13;MAPK14;MAPK9;ATG12;HOMER1;CCNB1;PIK3R1;PLK2;PRKAA1;SKP2;IL7R;EGF;PLK4;SETD7;MAPK10;BCL6;PIK3CA;TNFSF10;PIK3CB;PRKAG3;IRS1;CCNG2;BCL2L11;G6PC2;SOS1;AKT3;TGFB2;IRS4;IL10;FASLG;PRKAB2;NRAS;S1PR1;PRKAA2;GADD45A;PIK3R3;FOXO6;PLK3;PIK3CD
prerank,Taste transduction,-0.014109347442680777,-0.6596042014154984,0.8387096774193549,1.0,1.0,85/85,100.00%,PLCB4;PLCB1;PRKACA;CACNA1A;ASIC2;PKD1L3;GNG13;SCNN1B;SCNN1G;HCN4;PLCB2;GABRA5;ADCY4;P2RX2;ADCY6;PDE1B;GNB3;SCNN1A;CACNA1C;CALHM1;PKD2L1;HTR3B;HTR3A;PLCB3;TAS2R10;TAS2R30;TAS2R43;TAS2R46;TAS2R31;TAS2R19;TAS2R20;TAS2R50;TAS2R14;TAS2R13;TAS2R8;TAS2R9;TAS2R42;TAS2R7;ENTPD2;P2RX3;TRPM5;GABBR2;PRKACG;ADCY8;GABRA3;P2RY4;TAS2R41;TAS2R5;TAS2R4;TAS2R3;TAS2R38;TAS2R39;TAS2R40;TAS2R60;TAS2R16;GNAT3;PDE1C;GRM1;HTR1E;HTR1B;KCNK5;GRM4;ITPR3;GABBR1;GABRA1;GABRA6;HTR1A;TAS2R1;GABRA4;GABRA2;HTR3E;HTR3C;HTR3D;P2RY1;HTR1F;PDE1A;SCN3A;SCN9A;SCN2A;CHRM3;PRKACB;TAS1R2;HTR1D;TAS1R1;TAS1R3
prerank,"Valine, leucine and isoleucine degradation",-0.019557493057836432,-0.6443621664162553,0.6909090909090909,1.0,1.0,47/47,100.00%,IL4I1;BCAT2;BCKDHA;ACAA2;ALDH3A2;ACSF3;ABAT;ALDH6A1;IVD;ALDH2;PCCA;ACADS;AACS;ECHS1;ACADSB;BCAT1;ACAT1;ACAD8;AUH;ALDH1B1;HSD17B10;DLD;HIBADH;ACAT2;BCKDHB;HMGCLL1;AGXT2;MCCC2;ALDH7A1;OXCT1;HMGCS1;HADH;MCCC1;EHHADH;DBT;PCCB;ACAA1;HIBCH;AOX1;MCEE;HADHB;HADHA;ALDH9A1;HMGCS2;ACADM;OXCT2;HMGCL
prerank,Synaptic vesicle cycle,-0.015570830842797371,-0.6419945781647909,0.7555555555555555,1.0,1.0,78/78,100.00%,ATP6V1E1;AP2S1;NAPA;CLTCL1;AP2A1;SLC17A7;SLC32A1;DNM2;RAB3A;CACNA1A;SNAP25;CPLX4;SLC6A11;NSF;ATP6V0A1;AP2B1;CLTC;SLC6A4;VAMP2;ATP6V0D1;STX1B;SLC6A2;ATP6V0C;CPLX3;ATP6V1D;SLC17A8;STX2;UNC13C;ATP6V0A2;SYT1;SLC18A3;SLC6A13;SLC6A12;SLC18A2;UNC13A;SLC1A6;TCIRG1;SLC6A5;SLC17A6;STX3;SLC1A2;CACNA1B;AP2A2;DNM1;ATP6V1G1;CLTA;STXBP1;UNC13B;SLC1A1;ATP6V1C1;ATP6V0D2;ATP6V1H;SLC6A7;ATP6V1B2;SLC18A1;ATP6V0E2;ATP6V1F;ATP6V0A4;STX1A;RIMS1;ATP6V1G2;CPLX2;ATP6V0E1;CLTB;SLC1A3;SLC6A3;AP2M1;CPLX1;ATP6V1A;SLC6A1;ATP6V1B1;ATP6V1C2;ATP6V1E2;ATP6V1G3;DNM3;SLC1A7;ATP6V0B;SLC6A9
prerank,Natural killer cell mediated cytotoxicity,-0.011581625018704175,-0.6207818441064639,1.0,1.0,1.0,123/123,100.00%,ITGB2;PRKCG;IFNGR2;IFNAR1;IFNAR2;RAC2;BID;KIR3DL2;KIR3DL1;KIR2DL1;KIR2DL3;KIR3DL3;NCR1;MAPK1;PLCG1;TYROBP;HCST;ICAM1;PIK3R2;NFATC2;VAV1;MAP2K2;SHC2;NFATC1;RAC3;GRB2;RAF1;PRKCA;ICAM2;PLCG2;ITGAL;MAPK3;LAT;PRKCB;MAP2K1;SOS2;GZMB;SHC4;IFNG;PTPN11;KRAS;PTPN6;PRF1;PPP3CB;FAS;PAK1;KLRC4-KLRK1;KLRK1;KLRD1;KLRC3;KLRC2;KLRC1;HRAS;VAV2;PPP3R2;SYK;IFNA1;IFNA8;IFNA2;IFNA13;IFNA6;IFNA5;IFNA14;IFNA17;IFNA16;IFNA10;IFNA7;IFNA21;IFNB1;IFNA4;SHC3;TNFRSF10B;PTK2B;PPP3CC;TNFRSF10A;SH2D1A;ARAF;BRAF;RAC1;ULBP3;RAET1L;ULBP1;ULBP2;RAET1E;RAET1G;IFNGR1;FYN;NCR3;NCR2;TNF;MICB;MICA;HLA-B;HLA-C;HLA-E;HLA-A;HLA-G;CSF2;LCP2;PIK3R1;CASP3;PPP3CA;PIK3CA;TNFSF10;PIK3CB;SH3BP2;PPP3R1;ZAP70;SOS1;FCGR3A;FCGR3B;SH2D1B;FCER1G;CD247;CD48;CD244;FASLG;SHC1;NRAS;VAV3;PIK3R3;LCK;PIK3CD
prerank,Mismatch repair,-0.037923317917350444,-0.6186252771618624,0.6666666666666666,1.0,1.0,23/23,100.00%,LIG1;POLD1;PCNA;RPA1;MLH3;POLD3;RFC5;RFC3;POLD4;RPA4;SSBP1;RFC2;POLD2;RPA3;PMS2;MSH3;RFC1;RFC4;MLH1;MSH6;MSH2;EXO1;RPA2
prerank,Insulin resistance,-0.011576082079507045,-0.6094145436139701,0.9285714285714286,1.0,1.0,107/107,100.00%,CPT1B;PPARA;SLC27A5;NR1H2;GYS1;PIK3R2;AKT2;PPP1R3D;PCK1;INSR;CREB3L3;PTPN1;PYGB;TRIB3;SOCS3;G6PC3;MLX;STAT3;RPS6KB1;SLC2A4;SREBF1;PRKCB;PDPK1;AKT1;PYGL;IRS2;TBC1D4;PCK2;NFKBIA;PPP1R3E;PRKAB1;MLXIP;FOXO1;SLC27A2;PTPN11;ACACB;PPP1CC;MAPK8;PRKAG1;GYS2;TNFRSF1A;SLC27A1;PPP1R3C;PTEN;PRKCQ;OGA;RELA;PYGM;CPT1A;RPS6KB2;PPP1CA;CREB3L1;NR1H3;INS;PTPA;SLC27A4;CREB3;IKBKB;PPP1R3B;OGT;RPS6KA6;NOS3;RPS6KA3;PRKAG2;CREB3L2;PPP1R3A;CD36;MLXIPL;CREB5;IL6;RPS6KA2;TNF;GFPT2;MAPK9;PPARGC1B;SLC27A6;PIK3R1;PRKAA1;NFKB1;MAPK10;PPARGC1A;PIK3CA;SLC2A2;PIK3CB;GSK3B;PRKCD;PRKAG3;IRS1;G6PC2;CREB1;GFPT1;PRKCE;AKT3;AGT;PRKAB2;CREB3L4;CRTC2;SLC27A3;PRKAA2;PIK3R3;PPP1CB;RPS6KA1;PTPRF;PRKCZ;SLC2A1;MTOR;PIK3CD
prerank,JAK-STAT signaling pathway,-0.01159515819750719,-0.5780864889088058,0.85,1.0,1.0,162/162,100.00%,IFNGR2;IFNAR1;IL10RB;IFNAR2;OSM;LIF;CSF2RB;IL2RB;IL11;TYK2;PIK3R2;IL12RB1;AKT2;IFNL1;IFNL2;IFNL3;IL27RA;EPOR;EP300;PDGFB;PIAS4;BCL2L1;PIAS2;BCL2;SOCS3;PTPN2;SOCS6;GRB2;RAF1;GFAP;CSF3;STAT5B;STAT5A;STAT3;CSH2;GH2;CSH1;GH1;SOCS7;IL21R;IL4R;CTF1;SOCS1;CREBBP;PIAS1;AKT1;SOCS4;SOS2;SOCS2;IRF9;IFNG;IL22;PTPN11;IL17D;STAT2;IL23A;STAT6;PTPN6;CCND2;JAK3;STAM;IL2RA;IL15RA;IL10RA;CCND1;CNTF;HRAS;IFNE;IFNA1;IFNA8;IFNA2;IFNA13;IFNA6;IFNA5;IFNA14;IFNA17;IFNA16;IFNA10;IFNA7;IFNA21;IFNW1;IFNB1;IFNA4;IFNK;IL11RA;CNTFR;JAK2;MYC;IL7;FHL1;IL9R;IL13RA2;IL2RG;IL3RA;CSF2RA;CRLF2;LEP;EPO;EGFR;IL6;PDGFA;IFNGR1;IL22RA2;IL20RA;CDKN1A;CCND3;PIM1;PDGFRB;PRL;CSF2;PRLR;IL12B;IL9;IL4;IL13;IL5;TSLP;PIK3R1;IL6ST;GHR;IL3;OSMR;IL7R;LIFR;EGF;IL15;IL21;IL2;PDGFRA;THPO;PIK3CA;PIK3CB;IL12A;IL20RB;STAM2;CISH;IL5RA;AOX1;STAT4;STAT1;SOS1;SOCS5;AKT3;IL13RA1;IL24;IL20;IL19;IL10;PIAS3;MCL1;LEPR;JAK1;IL12RB2;IL23R;IL6R;PIK3R3;CSF3R;IL22RA1;IFNLR1;MPL;MTOR;PIK3CD
prerank,Folate biosynthesis,-0.02602052995941752,-0.5736030042382406,0.6582278481012658,1.0,1.0,26/26,100.00%,CBR1;MOCOS;GCH1;GPHN;PAH;TPH2;PCBD1;AKR1C3;PTS;TH;TPH1;FPGS;GGH;AKR1B10;AKR1B1;MOCS1;PCBD2;DHFR;MOCS2;QDPR;DHFR2;ALPI;ALPG;ALPP;SPR;ALPL
prerank,Nicotine addiction,-0.02286703683802018,-0.5706996590883435,0.6515151515151515,1.0,1.0,40/40,100.00%,GRIN2D;SLC17A7;SLC32A1;CACNA1A;CHRNA4;GRIN3B;GRIN2C;GRIN2A;CHRNA7;GABRG3;GABRA5;GABRB3;SLC17A8;GRIN2B;GRIA4;SLC17A6;CACNA1B;GRIN1;GRIN3A;CHRNA6;GABRA3;GABRQ;GABRE;GRIA3;GABRR1;GABRR2;GABRP;GABRG2;GABRA1;GABRA6;GABRB2;GRIA1;GRIA2;GABRB1;GABRA4;GABRA2;GABRG1;GABRR3;CHRNB2;GABRD
prerank,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,-0.029243256147051803,-0.5681332763776165,0.6973684210526315,1.0,1.0,26/26,100.00%,PIGP;PIGU;PIGQ;PIGT;PIGN;PIGW;PIGL;PIGS;MPPE1;PIGH;PIGB;DPM2;PIGO;GPAA1;PIGA;GPLD1;PIGY;PIGG;PIGX;PIGZ;PGAP1;PIGF;PIGM;PIGC;PIGK;PIGV
prerank,Adipocytokine signaling pathway,-0.012488795936659695,-0.5633975395775132,0.8363636363636363,1.0,1.0,68/68,100.00%,CPT1B;PPARA;CPT1C;AKT2;NFKBIB;PCK1;ACSBG2;STK11;SOCS3;G6PC3;STAT3;SLC2A4;AGRP;TRADD;ACSBG1;AKT1;IRS2;PCK2;NFKBIA;PRKAB1;CAMKK2;PTPN11;ACACB;MAPK8;PRKAG1;TNFRSF1A;ADIPOR2;ACSL5;PRKCQ;CHUK;RELA;CPT1A;TRAF2;RXRA;JAK2;IKBKB;IKBKG;PRKAG2;LEP;CD36;NPY;NFKBIE;TNF;RXRB;MAPK9;ACSL6;PRKAA1;ACSL1;NFKB1;MAPK10;PPARGC1A;ADIPOQ;PRKAG3;IRS1;ACSL3;G6PC2;POMC;AKT3;ACSL4;IRS4;ADIPOR1;RXRG;PRKAB2;LEPR;PRKAA2;TNFRSF1B;SLC2A1;MTOR
prerank,Fatty acid biosynthesis,-0.03579952267303103,-0.5509069743292656,0.6428571428571429,1.0,1.0,18/18,100.00%,ACSBG2;MCAT;FASN;OXSM;ACACA;ACSF3;ACSBG1;ACACB;ACSL5;OLAH;HSD17B8;ACSL6;ACSL1;CBR4;HTD2;ACSL3;ACSL4;MECR
prerank,Peroxisome,-0.0117168818747011,-0.5463638599655655,1.0,1.0,1.0,82/82,100.00%,SOD1;MLYCD;PEX26;NUDT19;MPV17L2;ECH1;PEX11G;SLC25A17;ACOT8;PXMP4;HAO1;ACOX1;PIPOX;PEX12;NOS2;MPV17L;NUDT7;DECR2;ABCD4;IDH2;PEX11A;DHRS4;SLC27A2;DAO;MVK;PXMP2;FAR2;ABCD2;PAOX;ACSL5;PHYH;PRDX5;CAT;PEX5;PEX16;FAR1;CRAT;BAAT;PEX2;EPHX2;ABCD1;GSTK1;PEX1;CROT;SOD2;PEX6;PEX3;PEX7;DDO;HMGCLL1;ECI2;AMACR;ACSL6;HSD17B4;NUDT12;ACSL1;ACOX3;EHHADH;ABCD3;PEX5L;ACAA1;HACL1;ACOX2;AGXT;IDH1;ACSL3;AGPS;PECR;PEX13;MPV17;GNPAT;ACSL4;PEX19;HAO2;PMVK;PEX11B;PRDX1;SCP2;XDH;PEX10;HMGCL;PEX14
prerank,"Alanine, aspartate and glutamate metabolism",-0.01889383040324747,-0.5422913440311048,0.7564102564102564,1.0,1.0,35/35,100.00%,IL4I1;ADSL;ASPA;GOT2;ABAT;GPT2;GLS2;GLUD1;GOT1;GAD2;ASRGL1;RIMKLB;FOLH1;ASS1;GPT;GOT1L1;GLUD2;ASNS;ASL;DDO;ALDH5A1;AGXT2;GFPT2;PPAT;NAT8L;NIT2;AGXT;CPS1;GLS;GAD1;GFPT1;CAD;GLUL;ALDH4A1;RIMKLA
prerank,RIG-I-like receptor signaling pathway,-0.01338552092981565,-0.5403953175973902,0.8409090909090909,1.0,1.0,69/69,100.00%,MAPK11;MAPK12;IRF3;PIN1;NFKBIB;RNF125;MAVS;TBKBP1;AZI2;TRIM25;DHX58;TRADD;CYLD;FADD;TRAF3;NFKBIA;TBK1;MAPK8;CHUK;NLRX1;RELA;TKFC;TRAF6;TRAF2;IRF7;IFNE;IFNA1;IFNA8;IFNA2;IFNA13;IFNA6;IFNA5;IFNA14;IFNA17;IFNA16;IFNA10;IFNA7;IFNA21;IFNW1;IFNB1;IFNA4;IFNK;DDX58;IKBKB;IKBKG;DDX3X;OTUD5;ATG5;MAP3K7;TNF;MAPK13;MAPK14;RIPK1;MAPK9;IL12B;ATG12;MAP3K1;NFKB1;MAPK10;IL12A;CXCL10;CXCL8;CASP8;CASP10;TANK;IFIH1;IKBKE;SIKE1;ISG15
prerank,Glycosaminoglycan biosynthesis,-0.013797222637001642,-0.5384141782840054,0.7169811320754716,1.0,1.0,53/53,100.00%,XYLT2;HS3ST3B1;HS3ST3A1;XYLT1;CHST4;ST3GAL2;CHST6;HS3ST2;GLCE;CHST14;CHSY1;FUT8;CHST11;HS6ST3;CSGALNACT2;CHST15;NDST2;CHST3;B3GAT3;CHST1;EXT2;B4GALT1;ST3GAL1;EXT1;NDST1;EXTL3;CSGALNACT1;HS6ST2;CHST7;CHPF2;CHST12;DSE;HS3ST5;UST;B4GALT7;CHSY3;NDST4;NDST3;HS3ST1;EXTL2;CHST2;CHST13;B4GALT4;B3GNT7;CHPF;HS6ST1;B3GNT2;B4GALT3;HS2ST1;EXTL1;B4GALT2;ST3GAL3;B3GALT6
prerank,Linoleic acid metabolism,-0.022291853178155775,-0.536768277872237,0.7183098591549296,1.0,1.0,28/28,100.00%,PLA2G3;PLA2G6;PLA2G4C;ALOX15;PLA2G10;CYP1A2;JMJD7-PLA2G4B;PLA2G4B;PLA2G4F;PLA2G4D;PLA2G4E;PLA2G1B;CYP2E1;CYP2C9;CYP2C19;CYP2C8;PLA2G12B;CYP3A4;PLA2G12A;PLA2G4A;CYP2J2;PLB1;PLA2G2C;PLA2G5;PLA2G2A;PLA2G2E;PLA2G2D;PLA2G2F
prerank,Other types of O-glycan biosynthesis,-0.01570571198232361,-0.5351635013565613,0.8245614035087719,1.0,1.0,47/47,100.00%,POFUT2;MFNG;POFUT1;GALNT1;RFNG;GALNT16;POMT2;B3GLCT;GALNT9;GALNT4;POC1B-GALNT4;GXYLT1;GALNT6;GALNT8;COLGALT1;GALNT18;GALNT12;POMT1;B4GALT1;C1GALT1C1;OGT;GALNT11;GALNTL5;PLOD3;GALNT17;C1GALT1;LFNG;GALNT10;GALNT7;GALNTL6;ST6GAL1;XXYLT1;POGLUT1;EOGT;GALNT15;GXYLT2;GALNT3;GALNT13;GALNT5;ST6GAL2;COLGALT2;C1GALT1C1L;GALNT2;B4GALT3;GALNT14;B4GALT2;ST3GAL3
prerank,Notch signaling pathway,-0.01412825950595896,-0.5312517549278374,0.825,1.0,1.0,59/59,100.00%,MFNG;PSENEN;NUMBL;DLL3;EP300;JAG1;RBPJL;TLE2;TLE6;RFNG;KAT2B;KAT2A;DVL2;TLE7;ATXN1L;CREBBP;TLE3;NUMB;PSEN1;APH1B;DLL4;JAG2;SNW1;NCOR2;DTX1;DTX3;CTBP2;NOTCH3;MAML2;NOTCH1;DTX4;TLE4;TLE1;HEY1;DTX2;LFNG;DLL1;HEY2;HDAC2;PTCRA;NOTCH4;MAML1;ATXN1;MAML3;RBPJ;DVL3;HES1;DTX3L;CTBP1;CIR1;ADAM17;PSEN2;NCSTN;NOTCH2;APH1A;HEYL;HDAC1;HES5;DVL1
prerank,Staphylococcus aureus infection,-0.01189942296768021,-0.5308901993821958,0.9473684210526315,1.0,1.0,91/91,100.00%,ITGB2;FPR3;FPR2;FPR1;C5AR1;FCAR;ICAM1;C3;CFD;KRT40;KRT23;KRT20;KRT12;KRT17;KRT16;KRT39;KRT14;KRT9;KRT19;KRT26;KRT25;KRT15;KRT13;KRT36;KRT35;KRT32;KRT38;KRT37;KRT31;KRT34;KRT33B;KRT33A;KRT10;KRT28;KRT27;DSG1;KRT24;ITGAL;ITGAM;SELPLG;MBL2;KRT18;C1R;C1S;C3AR1;C5;DEFA3;DEFA5;DEFB103B;DEFB4B;DEFB103A;DEFB4A;DEFA1B;DEFA1;DEFA4;DEFA6;DEFB1;PLG;C2;HLA-DPB1;HLA-DPA1;HLA-DOA;HLA-DRB1;HLA-DMB;HLA-DOB;HLA-DQA2;HLA-DQB1;HLA-DQA1;HLA-DMA;C4B;C4A;CFB;HLA-DRA;HLA-DRB5;CFI;FGG;MASP1;CAMP;IL10;CFH;FCGR3A;FCGR3B;FCGR2B;FCGR2A;SELP;FCGR1A;PTAFR;C1QB;C1QC;C1QA;MASP2
prerank,Chronic myeloid leukemia,-0.011565357719203872,-0.526795490190276,0.9565217391304348,1.0,1.0,76/76,100.00%,RUNX1;BCR;MAPK1;CRKL;BAX;PIK3R2;TGFB1;AKT2;MAP2K2;SHC2;GADD45B;E2F1;BCL2L1;SMAD4;GRB2;RAF1;TGFBR2;STAT5B;STAT5A;TP53;CRK;MAPK3;TGFB3;SMAD3;MAP2K1;AKT1;SOS2;NFKBIA;RB1;SHC4;PTPN11;MDM2;CDK4;CTBP2;KRAS;CDKN1B;CHUK;RELA;BAD;GAB2;CBL;CCND1;DDB2;HRAS;TGFBR1;ABL1;CDKN2A;SHC3;GADD45G;MYC;IKBKB;IKBKG;ARAF;BRAF;CDK6;HDAC2;CDKN1A;BAK1;E2F3;POLK;PIK3R1;NFKB1;PIK3CA;PIK3CB;MECOM;CTBP1;SOS1;AKT3;TGFB2;SHC1;NRAS;GADD45A;PIK3R3;HDAC1;E2F2;PIK3CD
prerank,Complement and coagulation cascades,-0.011897288733446925,-0.5255403433178123,0.8157894736842105,1.0,1.0,85/85,100.00%,ITGB2;C5AR1;SERPIND1;PLAUR;PROCR;C3;CFD;THBD;SERPINB2;VTN;SERPINF2;ITGAM;ITGAX;BDKRB1;BDKRB2;SERPINA5;SERPINA1;F10;F7;CPB2;MBL2;VWF;C1R;C1S;PLAU;F2RL3;CD59;F2;C3AR1;A2M;C8G;SERPING1;C5;PLAT;CLU;F8;F9;VSIG4;SERPINE1;PLG;C2;C4B;C4A;CFB;F12;F13A1;F2R;F2RL2;C6;C7;C9;F11;KLKB1;CFI;FGA;FGB;FGG;MASP1;F3;KNG1;PROS1;TFPI;PROC;CR1L;CR1;CR2;CD55;C4BPA;C4BPB;CD46;CFH;CFHR3;F13B;CFHR5;CFHR2;CFHR4;CFHR1;F5;SERPINC1;C8A;C8B;C1QB;C1QC;C1QA;MASP2
prerank,Amino sugar and nucleotide sugar metabolism,-0.019527051236116085,-0.5091537217025315,0.75,1.0,1.0,46/46,100.00%,GPI;PMM1;CYB5R3;NANP;GALK1;PMM2;AMDHD2;MPI;HEXA;GNPNAT1;CMAS;HK1;HKDC1;CYB5R2;UAP1L1;NANS;GNE;GALT;RENBP;GCK;CYB5R4;PGM3;GFPT2;GMDS;HK3;GNPDA1;HEXB;PGM2;UGDH;GNPDA2;GMPPB;GMPPA;UXS1;UGP2;NAGK;GFPT1;HK2;CHIT1;UAP1;NPL;CYB5R1;PGM1;CHIA;FPGT;CYB5RL;GALE
prerank,Fc epsilon RI signaling pathway,-0.01156224791610648,-0.4989217570671791,0.9272727272727272,1.0,1.0,67/67,100.00%,MAPK11;MAPK12;RAC2;PLA2G4C;MAPK1;PLCG1;MAP2K7;PIK3R2;AKT2;VAV1;MAP2K2;RAC3;MAP2K6;GRB2;RAF1;PRKCA;MAP2K3;MAP2K4;PLCG2;MAPK3;LAT;PDPK1;MAP2K1;JMJD7-PLA2G4B;PLA2G4B;PLA2G4F;PLA2G4D;PLA2G4E;AKT1;SOS2;ALOX5AP;MAPK8;ALOX5;KRAS;GAB2;MS4A2;HRAS;VAV2;SYK;LYN;BTK;RAC1;FYN;TNF;MAPK13;MAPK14;CSF2;MAPK9;LCP2;IL4;IL13;IL5;PIK3R1;IL3;MAPK10;PIK3CA;PIK3CB;INPP5D;SOS1;AKT3;FCER1G;PLA2G4A;FCER1A;NRAS;VAV3;PIK3R3;PIK3CD
prerank,N-Glycan biosynthesis,-0.01591614906832298,-0.49660008499787506,0.8070175438596491,1.0,1.0,50/50,100.00%,ALG12;RPN2;DPM1;MGAT3;MGAT5B;STT3B;ALG1;MAN2A2;MGAT2;FUT8;ALG11;DAD1;MGAT4C;ALG5;ALG10B;ALG10;ALG9;DPAGT1;ALG8;STT3A;GANAB;MAN1B1;DOLPP1;DOLK;ALG2;DPM2;B4GALT1;TUSC3;ALG13;MAN1A1;MGAT1;MGAT4B;MAN2A1;MGAT4D;SRD5A3;ALG3;ST6GAL1;ALG14;RPN1;MGAT5;ST6GAL2;MGAT4A;MOGS;B4GALT3;DPM3;MAN1A2;ALG6;MAN1C1;DDOST;B4GALT2
prerank,Primary bile acid biosynthesis,-0.03520181378837147,-0.49638658181425943,0.6794871794871795,1.0,1.0,17/17,100.00%,SLC27A5;ACOT8;HSD3B7;CYP46A1;CH25H;AKR1C4;BAAT;CYP7B1;CYP7A1;AKR1D1;CYP39A1;AMACR;HSD17B4;CYP8B1;ACOX2;CYP27A1;SCP2
prerank,Pancreatic cancer,-0.011565357719203872,-0.49244472721488786,0.925,1.0,1.0,76/76,100.00%,RAC2;MAPK1;BAX;PIK3R2;TGFB1;AKT2;GADD45B;E2F1;BCL2L1;SMAD2;SMAD4;ERBB2;RAC3;RAF1;TGFBR2;STAT3;RPS6KB1;PLD2;TP53;MAPK3;RALBP1;TGFB3;SMAD3;MAP2K1;RAD51;AKT1;RB1;BRCA2;CDK4;MAPK8;KRAS;CHUK;RELA;BAD;CCND1;RPS6KB2;DDB2;TGFBR1;RALGDS;CDKN2A;GADD45G;IKBKB;IKBKG;ARHGEF6;ARAF;BRAF;CDK6;EGFR;RALA;RAC1;CDKN1A;VEGFA;BAK1;E2F3;MAPK9;POLK;PIK3R1;EGF;NFKB1;MAPK10;PIK3CA;PLD1;PIK3CB;STAT1;RALB;TGFA;AKT3;TGFB2;CASP9;JAK1;GADD45A;PIK3R3;E2F2;CDC42;MTOR;PIK3CD
prerank,alpha-Linolenic acid metabolism,-0.022289192576236797,-0.48901330806666937,0.7763157894736842,1.0,1.0,24/24,100.00%,PLA2G3;PLA2G6;PLA2G4C;ACOX1;PLA2G10;JMJD7-PLA2G4B;PLA2G4B;PLA2G4F;PLA2G4D;PLA2G4E;PLA2G1B;PLA2G12B;FADS2;PLA2G12A;ACOX3;ACAA1;PLA2G4A;PLB1;PLA2G2C;PLA2G5;PLA2G2A;PLA2G2E;PLA2G2D;PLA2G2F
prerank,Non-small cell lung cancer,-0.011563975377995578,-0.4814706972311928,0.9148936170212766,1.0,1.0,72/72,100.00%,PRKCG;MAPK1;BAX;PLCG1;PIK3R2;AKT2;MAP2K2;STK4;GADD45B;E2F1;ERBB2;GRB2;RARB;RAF1;STAT5B;STAT5A;STAT3;PRKCA;TP53;PLCG2;MAPK3;PRKCB;PDPK1;MAP2K1;AKT1;SOS2;RB1;CDK4;KIF5A;RET;KRAS;JAK3;KIF5B;BAD;CCND1;DDB2;HRAS;RXRA;CDKN2A;GADD45G;ARAF;BRAF;MET;CDK6;HGF;EGFR;FOXO3;CDKN1A;BAK1;RXRB;E2F3;POLK;PIK3R1;EGF;PIK3CA;PIK3CB;KIF5C;RASSF1;FHIT;TGFA;SOS1;EML4;AKT3;RASSF5;RXRG;CASP9;NRAS;GADD45A;PIK3R3;ALK;E2F2;PIK3CD
prerank,Hedgehog signaling pathway,-0.016008601636700318,-0.4812930260401077,0.8333333333333334,1.0,1.0,56/56,100.00%,CSNK1E;TPTEP2-CSNK1E;GRK3;MEGF8;PRKACA;CSNK1G2;BCL2;CSNK1D;SPOP;SMURF2;ARRB2;MOSMO;MGRN1;CSNK1G1;KIF7;ARRB1;CSNK1A1L;GLI1;DHH;CCND2;BTRC;SUFU;CDON;CCND1;GRK2;SCUBE2;PTCH1;PRKACG;GAS1;SHH;CUL1;SMO;SMURF1;GLI3;IQCE;FBXW11;CSNK1A1;KIF3A;CSNK1G3;BOC;HHIP;EVC;EVC2;GSK3B;HHATL;CUL3;IHH;LRP2;SPOPL;GLI2;HHAT;DISP1;GPR161;EFCAB7;PRKACB;PTCH2
prerank,Glycosphingolipid biosynthesis,-0.01570477413190816,-0.4665265094277641,0.7962962962962963,1.0,1.0,45/45,100.00%,B3GALT5;FUT2;FUT1;FUT5;FUT3;FUT6;NAGA;A4GALT;ST8SIA5;ST3GAL2;HEXA;B3GNT4;B4GALNT1;ST8SIA1;B3GNT3;ST3GAL4;FUT4;FUT7;ABO;ST6GALNAC4;GBGT1;ST6GALNAC6;B4GALT1;ST3GAL1;FUT9;B3GALT4;GCNT2;HEXB;B3GNT5;SLC33A1;B3GALNT1;B4GALT4;ST3GAL6;GLB1;B3GALT1;B3GNT2;ST3GAL5;GLA;B3GALT2;B4GALT3;ST6GALNAC3;ST6GALNAC5;A3GALT2;B4GALT2;ST3GAL3
prerank,Butanoate metabolism,-0.019546404058490004,-0.4515027946415966,0.8192771084337349,1.0,1.0,28/28,100.00%,ACSM2B;ACSM2A;ACSM5;ABAT;ACSM3;ACSM1;L2HGDH;ACADS;AACS;ECHS1;ACSM6;GAD2;ACAT1;ACSM4;ACAT2;HMGCLL1;ALDH5A1;OXCT1;HMGCS1;BDH2;HADH;BDH1;EHHADH;GAD1;HADHA;HMGCS2;OXCT2;HMGCL
prerank,Circadian rhythm,-0.018055928611931834,-0.4437858091631807,0.7567567567567568,1.0,1.0,31/31,100.00%,CSNK1E;TPTEP2-CSNK1E;RBX1;CSNK1D;NR1D1;PER1;RORA;FBXL3;PRKAB1;CRY1;PRKAG1;BHLHE41;BTRC;CRY2;ARNTL;RORB;PRKAG2;CUL1;FBXW11;SKP1;PRKAA1;CLOCK;NPAS2;PER2;BHLHE40;PRKAG3;CREB1;RORC;PRKAB2;PRKAA2;PER3
prerank,Various types of N-glycan biosynthesis,-0.015701492537313434,-0.4336783037790875,0.7611940298507462,1.0,1.0,38/38,100.00%,ALG12;CHST8;RPN2;CHST9;STT3B;ALG1;HEXA;MAN2A2;MGAT2;FUT8;ALG11;DAD1;MGAT4C;B4GALNT3;ALG9;STT3A;MAN1B1;B4GALNT4;ALG2;B4GALT1;TUSC3;ALG13;MAN1A1;MGAT1;MGAT4B;MAN2A1;HEXB;MGAT4D;ALG3;ALG14;RPN1;MGAT4A;B4GALT3;MAN1A2;MAN1C1;DDOST;B4GALT2;ST3GAL3
prerank,Melanoma,-0.011563975377995578,-0.4263647810054861,0.9387755102040817,1.0,1.0,72/72,100.00%,MAPK1;BAX;FGF21;PIK3R2;AKT2;MAP2K2;PDGFB;FGF22;GADD45B;E2F1;RAF1;TP53;CDH1;MAPK3;IGF1R;MAP2K1;AKT1;IGF1;RB1;FGF7;MDM2;FGF9;CDK4;KRAS;FGF6;FGF23;PTEN;FGF8;PDGFD;BAD;CCND1;FGF19;FGF3;FGF4;DDB2;HRAS;CDKN2A;GADD45G;FGFR1;FGF17;FGF20;FGF16;ARAF;BRAF;MET;CDK6;HGF;EGFR;PDGFA;CDKN1A;BAK1;PDGFRB;E2F3;FGF18;FGF1;POLK;PIK3R1;FGF10;EGF;FGF2;FGF5;PDGFC;PDGFRA;PIK3CA;PIK3CB;MITF;AKT3;NRAS;GADD45A;PIK3R3;E2F2;PIK3CD
prerank,Fanconi anemia pathway,-0.01158762393979214,-0.42101878830503364,0.9444444444444444,1.0,1.0,54/54,100.00%,ERCC1;TOP3B;FAAP24;POLI;CENPX;FAAP100;BRIP1;EME1;BRCA1;RAD51C;TOP3A;ERCC4;FANCA;RPA1;SLX1B;SLX1A;EME2;TELO2;RMI2;PALB2;SLX4;FAN1;FANCI;BLM;RAD51;FANCM;BRCA2;MUS81;FANCF;FANCC;RMI1;FANCG;RPA4;FANCB;RPA3;PMS2;REV3L;POLH;FANCE;POLK;HES1;ATR;POLN;ATRIP;WDR48;MLH1;FANCD2;REV1;FANCL;UBE2T;USP1;RPA2;CENPS;CENPS-CORT
prerank,GnRH secretion,-0.0115612116866822,-0.4203849070525302,0.9245283018867925,1.0,1.0,64/64,100.00%,PRKCG;KCNJ6;PLCB4;PLCB1;MAPK1;LHB;KCNN4;PIK3R2;KCNN1;AKT2;KISS1R;MAP2K2;CACNA1I;HCN2;GNA11;GNRH2;CACNA1G;RAF1;PRKCA;ARRB2;MAPK3;PRKCB;CACNA1H;PLCB2;MAP2K1;ARRB1;AKT1;ESR2;TRPC4;KRAS;ITPR2;CACNA1C;KCNJ5;PLCB3;KCNJ11;HRAS;GABBR2;GNAQ;GNRH1;TRPC5;CACNA1F;GPER1;CGA;ITPR3;GABBR1;KCNN2;PIK3R1;HCN1;SPP1;PIK3CA;PIK3CB;TRPC1;CACNA1D;ITPR1;KCNJ3;AKT3;CACNA1S;KISS1;KCNJ9;HCN3;KCNN3;NRAS;PIK3R3;PIK3CD
prerank,SNARE interactions in vesicular transport,-0.018027160125354425,-0.41769994253265424,0.8309859154929577,1.0,1.0,33/33,100.00%,SNAP29;STX16;GOSR2;GOSR1;VAMP2;STX8;STX4;STX1B;SNAP23;VTI1B;STX2;VAMP1;VTI1A;USE1;STX5;STX3;BET1L;STX17;VAMP7;BET1;STX1A;YKT6;STX11;STX7;BNIP1;STX18;STX19;VAMP5;VAMP8;STX6;VAMP4;SEC22B;VAMP3
prerank,Acute myeloid leukemia,-0.01156224791610648,-0.4139842458426529,0.9272727272727272,1.0,1.0,67/67,100.00%,RUNX1;MAPK1;CEBPA;PIK3R2;AKT2;MAP2K2;GRB2;RAF1;MPO;RARA;JUP;STAT5B;STAT5A;STAT3;RPS6KB1;MAPK3;ITGAM;PML;BCL2A1;MAP2K1;AKT1;SOS2;CEBPE;FLT3;CCNA1;DUSP6;KRAS;TCF7L2;CHUK;ZBTB16;RELA;BAD;CCND1;RPS6KB2;SPI1;HRAS;MYC;RUNX1T1;EIF4EBP1;IKBKB;IKBKG;PIM2;ARAF;BRAF;CSF1R;PIM1;PPARD;CSF2;CD14;TCF7;PIK3R1;IL3;NFKB1;LEF1;CCNA2;KIT;PIK3CA;PIK3CB;PER2;TCF7L1;SOS1;AKT3;FCGR1A;NRAS;PIK3R3;MTOR;PIK3CD
prerank,Galactose metabolism,-0.015906649158409933,-0.37569176549030825,0.8108108108108109,1.0,1.0,30/30,100.00%,PFKL;GALK1;GAA;G6PC3;GANC;LALBA;PFKM;HK1;HKDC1;PFKP;B4GALT1;GALT;AKR1B10;AKR1B1;MGAM;MGAM2;GCK;HK3;PGM2;SI;GLB1;G6PC2;LCT;UGP2;HK2;GALM;GLA;PGM1;GALE;B4GALT2
prerank,Fatty acid elongation,-0.015427769985974756,-0.3725878794200479,0.8289473684210527,1.0,1.0,27/27,100.00%,ACAA2;ACOT1;ACOT4;ACOT2;HACD3;ECHS1;TECR;HACD1;ELOVL3;HSD17B12;HACD4;ELOVL4;ELOVL5;PPT2;ELOVL2;ELOVL7;ELOVL6;HADH;HACD2;HADHB;HADHA;THEM4;THEM5;PPT1;MECR;ACOT7;ELOVL1
prerank,Terpenoid backbone biosynthesis,-0.017185821697099892,-0.36577013970387273,0.8734177215189873,1.0,1.0,22/22,100.00%,MVD;FNTB;MVK;PDSS1;IDI1;IDI2;ACAT1;RCE1;FNTA;ACAT2;NUS1;PDSS2;HMGCR;HMGCS1;PCYOX1;GGPS1;FDPS;HMGCS2;PMVK;ZMPSTE24;DHDDS;ICMT
prerank,Type II diabetes mellitus,-0.01155499820852741,-0.33863699339351594,0.9833333333333333,1.0,1.0,46/46,100.00%,MAPK1;PIK3R2;CACNA1A;INSR;SOCS3;CACNA1G;SLC2A4;MAPK3;SOCS1;PKM;SOCS4;IRS2;SOCS2;PDX1;MAPK8;CACNA1C;HK1;HKDC1;CACNA1B;INS;ABCC8;KCNJ11;MAFA;IKBKB;GCK;TNF;MAPK9;HK3;PIK3R1;MAPK10;ADIPOQ;PIK3CA;SLC2A2;PIK3CB;CACNA1D;PRKCD;IRS1;HK2;PRKCE;IRS4;CACNA1E;PKLR;PIK3R3;PRKCZ;MTOR;PIK3CD
prerank,Glyoxylate and dicarboxylate metabolism,-0.015518218985944075,-0.3352446445840212,0.9242424242424242,1.0,1.0,29/29,100.00%,ACSS2;ACO2;ACSS1;HAO1;AFMID;SHMT1;GCSH;PGP;PCCA;CS;SHMT2;HOGA1;ACAT1;CAT;ACO1;GRHPR;GLDC;DLD;MDH2;ACAT2;PCCB;AMT;GLYCTK;AGXT;MDH1;MCEE;GLUL;HAO2;HYI
prerank,Carbohydrate digestion and absorption,-0.01080855129583184,-0.33383766336690734,1.0,1.0,1.0,46/46,100.00%,SLC5A1;PLCB4;PLCB1;ATP1A3;PIK3R2;AKT2;G6PC3;ATP1B2;PRKCB;PLCB2;AKT1;HK1;HKDC1;SLC37A4;FXYD2;PLCB3;ATP1B4;MGAM;MGAM2;GNAT3;HK3;PIK3R1;PIK3CA;SLC2A2;PIK3CB;SI;ATP1B3;CACNA1D;G6PC2;LCT;HK2;AKT3;ATP1B1;ATP1A4;ATP1A2;ATP1A1;AMY1C;AMY1B;AMY1A;AMY2A;AMY2B;PIK3R3;TAS1R2;TAS1R3;PIK3CD;SLC2A5
prerank,Biosynthesis of unsaturated fatty acids,-0.015427769985974756,-0.3334198800629834,0.8311688311688312,1.0,1.0,27/27,100.00%,ACOX1;ACOT1;ACOT4;ACOT2;HACD3;TECR;HACD1;ELOVL3;SCD;FADS1;FADS2;HSD17B12;BAAT;HACD4;ELOVL4;ELOVL5;ELOVL2;HSD17B4;ELOVL7;ELOVL6;SCD5;ACOX3;HACD2;ACAA1;SCP2;ACOT7;ELOVL1
prerank,Thiamine metabolism,-0.026011991766846643,-0.33247313627846203,0.7317073170731707,1.0,1.0,15/15,100.00%,NFS1;AK7;THTPA;AK8;AK1;TPK1;ALPI;ALPG;ALPP;ACP1;NTPCR;AK4;AK5;AK2;ALPL
prerank,Aldosterone-regulated sodium reabsorption,-0.011551893973314228,-0.3045306082850952,1.0,1.0,1.0,37/37,100.00%,PRKCG;MAPK1;ATP1A3;PIK3R2;INSR;NEDD4L;PRKCA;ATP1B2;HSD11B2;MAPK3;SLC9A3R2;SCNN1B;SCNN1G;PRKCB;PDPK1;IGF1;FXYD4;KRAS;SCNN1A;KCNJ1;FXYD2;INS;ATP1B4;SGK1;PIK3R1;NR3C2;PIK3CA;PIK3CB;ATP1B3;IRS1;ATP1B1;ATP1A4;ATP1A2;ATP1A1;PIK3R3;SFN;PIK3CD
prerank,Mannose type O-glycan biosynthesis,-0.015693996897004417,-0.2974682234804858,0.9146341463414634,1.0,1.0,22/22,100.00%,LARGE1;FKRP;MGAT5B;POMT2;RXYLT1;B3GAT1;FUT4;B4GAT1;LARGE2;POMT1;FKTN;B4GALT1;POMK;FUT9;B3GAT2;POMGNT2;CHST10;B3GALNT2;B4GALT3;POMGNT1;B4GALT2;ST3GAL3
prerank,Other glycan degradation,-0.01956982190268787,-0.2774972371892829,0.8875,1.0,1.0,17/17,100.00%,MAN2B1;ENGASE;MAN2C1;HEXA;NEU3;GBA2;FUCA2;NEU1;HEXB;MANBA;AGA;MAN2B2;GLB1;NEU2;NEU4;GBA;FUCA1
prerank,Nicotinate and nicotinamide metabolism,-0.011372115929916724,-0.27572066095766495,0.9861111111111112,1.0,1.0,35/35,100.00%,ASPDH;SIRT2;SIRT6;NMRK2;SIRT7;NT5C;NT5M;QPRT;NADSYN1;PNP;SIRT4;SIRT1;NT5C2;NNMT;SIRT3;NMRK1;NAPRT;NAMPT;ENPP1;ENPP3;NT5E;SIRT5;NNT;NADK2;NUDT12;CD38;BST1;NMNAT3;AOX1;NMNAT2;NT5C1B;NT5C1B-RDH14;NT5C1A;NADK;NMNAT1
prerank,Pantothenate and CoA biosynthesis,-0.014649282453680221,-0.2610562765841423,0.9358974358974359,1.0,1.0,21/21,100.00%,UPB1;BCAT2;PANK2;GADL1;COASY;ALDH3A2;PPCDC;ALDH2;BCAT1;PANK1;AASDHPPT;ALDH1B1;DPYS;ENPP1;ENPP3;VNN1;VNN3;VNN2;PANK3;DPYD;PPCS
prerank,Pentose phosphate pathway,-0.010922764712904381,-0.2588520569838252,1.0,0.996550211499295,1.0,30/30,100.00%,PFKL;GPI;ALDOC;ALDOA;PFKM;DERA;PGLS;RPEL1;PFKP;TALDO1;FBP1;FBP2;ALDOB;IDNK;TKTL1;G6PD;RGN;PRPS2;PRPS1L1;TKTL2;PGM2;GLYCTK;TKT;RPE;RBKS;RPIA;PRPS1;PGM1;PGD;H6PD
prerank,Nitrogen metabolism,-0.010739536410011635,-0.16160346549653792,1.0,0.9996083346388845,1.0,17/17,100.00%,CA5A;CA4;CA7;CA12;GLUD1;CA9;CA3;CA1;CA13;CA2;CA8;GLUD2;CA5B;CPS1;GLUL;CA14;CA6
